| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.001 | 0.907 | Creatine kinase inhibitor | 0.486 0.002 CID_359 0.137 0.03 CID_152432 | ||
| 0.902 | 0.004 | 0.902 | Antioxidant | 0.719 0.005 CID_359 0.526 0.017 CID_152432 | ||
| 0.887 | 0.003 | 0.887 | Free radical scavenger | 0.735 0.005 CID_359 0.436 0.024 CID_152432 | ||
| 0.844 | 0.003 | 0.844 | Histamine release inhibitor | 0.561 0.014 CID_359 0.423 0.064 CID_152432 | ||
| 0.808 | 0.012 | 0.808 | Transcription factor NF kappa B inhibitor | 0.456 0.052 CID_359 0.53 0.04 CID_152432 | ||
| 0.808 | 0.016 | 0.808 | Apoptosis agonist | 0.652 0.039 CID_359 0.537 0.064 CID_152432 | ||
| 0.794 | 0.012 | 0.794 | Caspase 9 stimulant | 0.768 0.015 CID_359 0.641 0.031 CID_152432 | ||
| 0.789 | 0.007 | 0.789 | Cyclophilin D inhibitor | 0.38 0.102 CID_359 0.527 0.043 CID_152432 | ||
| 0.797 | 0.018 | 0.797 | Alpha-glucosidase inhibitor | 0.416 0.108 CID_359 0.246 0.19 CID_152432 | ||
| 0.774 | 0.008 | 0.774 | 15-Lipoxygenase inhibitor | 0.457 0.052 CID_359 0.308 0.127 CID_152432 | ||
| 0.764 | 0.002 | 0.764 | Carbonic anhydrase III inhibitor | 0.351 0.004 CID_359 0.179 0.02 CID_152432 | ||
| 0.74 | 0.005 | 0.74 | Amyloid beta aggregation inhibitor | 0.624 0.007 CID_359 0.331 0.039 CID_152432 | ||
| 0.736 | 0.024 | 0.736 | Antiinflammatory | 0.564 0.064 CID_359 0.388 0.147 CID_152432 | ||
| 0.711 | 0.002 | 0.711 | Carbonic anhydrase VI inhibitor | 0.292 0.006 CID_359 0.15 0.021 CID_152432 | ||
| 0.71 | 0.005 | 0.71 | Hypoglycemic | 0.47 0.018 CID_359 0.605 0.008 CID_152432 | ||
| 0.704 | 0.008 | 0.879 | Aldehyde oxidase inhibitor | 0.879 0.004 CID_359 0.538 0.028 CID_152432 | CID_359 | |
| 0.668 | 0.004 | 0.668 | NOS3 expression enhancer | 0.538 0.005 CID_359 0.208 0.038 CID_152432 | ||
| 0.667 | 0.003 | 0.667 | Melanin inhibitor | 0.372 0.014 CID_359 0.391 0.012 CID_152432 | ||
| 0.649 | 0.002 | 0.649 | Carbonic anhydrase XV inhibitor | 0.341 0.005 CID_359 0.105 0.061 CID_152432 | ||
| 0.651 | 0.007 | 0.651 | Nitric oxide antagonist | 0.419 0.023 CID_359 0.406 0.025 CID_152432 | ||
| 0.638 | 0.004 | 0.638 | Monophenol monooxygenase inhibitor | 0.311 0.017 CID_359 0.271 0.021 CID_152432 | ||
| 0.637 | 0.006 | 0.637 | Apoptosis antagonist | 0.449 0.028 CID_359 0.343 0.059 CID_152432 | ||
| 0.632 | 0.002 | 0.632 | Histidine decarboxylase inhibitor | 0.435 0.003 CID_359 0.097 0.033 CID_152432 | ||
| 0.627 | 0.004 | 0.627 | Hepatoprotectant | 0.325 0.023 CID_359 0.188 0.073 CID_152432 | ||
| 0.615 | 0.003 | 0.615 | Cystathionine beta-synthase inhibitor | 0.527 0.003 CID_359 0.306 0.009 CID_152432 | ||
| 0.601 | 0.004 | 0.601 | Amylase inhibitor | 0.43 0.008 CID_359 0.381 0.01 CID_152432 | ||
| 0.595 | 0.013 | 0.595 | Spasmolytic | 0.33 0.059 CID_359 0.195 0.124 CID_152432 | ||
| 0.567 | 0.01 | 0.567 | Antiamyloidogenic | 0.292 0.054 CID_359 0.303 0.051 CID_152432 | ||
| 0.554 | 0.004 | 0.554 | Lipid peroxidase inhibitor | 0.504 0.005 CID_359 0.212 0.037 CID_152432 | ||
| 0.551 | 0.003 | 0.551 | DNA polymerase I inhibitor | 0.285 0.013 CID_359 0.274 0.014 CID_152432 | ||
| 0.555 | 0.014 | 0.57 | Caspase 3 stimulant | 0.57 0.012 CID_359 0.322 0.069 CID_152432 | CID_359 | |
| 0.541 | 0.003 | 0.541 | Neurotrophic factor enhancer | 0.381 0.007 CID_359 0.368 0.008 CID_152432 | ||
| 0.536 | 0.004 | 0.71 | Estrogen receptor beta antagonist | 0.71 0.003 CID_359 0.108 0.05 CID_152432 | CID_359 | |
| 0.539 | 0.014 | 0.539 | Lipoxygenase inhibitor | 0.361 0.048 CID_359 0.347 0.051 CID_152432 | ||
| 0.527 | 0.004 | 0.73 | Estrogen antagonist | 0.73 0.003 CID_359 0.131 0.037 CID_152432 | CID_359 | |
| 0.523 | 0.01 | 0.523 | Vasodilator | 0.312 0.044 CID_359 0.316 0.043 CID_152432 | ||
| 0.508 | 0.009 | 0.738 | Peroxidase inhibitor | 0.738 0.002 CID_359 0.528 0.008 CID_152432 | CID_359 | |
| 0.484 | 0.005 | 0.486 | 5 Hydroxytryptamine uptake stimulant | 0.486 0.005 CID_359 0.366 0.021 CID_152432 | CID_359 | |
| 0.475 | 0.004 | 0.475 | Estrogen receptor alpha antagonist | 0.175 0.009 CID_359 0.105 0.024 CID_152432 | ||
| 0.47 | 0.003 | 0.47 | M18 aspartyl aminopeptidase inhibitor | 0.41 0.005 CID_359 0.116 0.074 CID_152432 | ||
| 0.479 | 0.017 | 0.479 | Hypoxia-inducible factor 1 alpha inhibitor | 0.374 0.037 CID_359 0.313 0.06 CID_152432 | ||
| 0.462 | 0.004 | 0.462 | Aromatase inhibitor | 0.113 0.019 CID_359 0.06 0.041 CID_152432 | ||
| 0.464 | 0.008 | 0.464 | Topoisomerase II inhibitor | 0.406 0.01 CID_359 | ||
| 0.457 | 0.004 | 0.457 | Cyclooxygenase 3 inhibitor | 0.217 0.014 CID_359 0.165 0.037 CID_152432 | ||
| 0.487 | 0.044 | 0.58 | Antibacterial | 0.405 0.074 CID_359 0.58 0.022 CID_152432 | CID_152432 | |
| 0.436 | 0.004 | 0.576 | Estrogen agonist | 0.576 0.003 CID_359 0.122 0.014 CID_152432 | CID_359 | |
| 0.426 | 0.002 | 0.426 | Fatty acid synthase inhibitor | 0.121 0.006 CID_359 0.079 0.019 CID_152432 | ||
| 0.424 | 0.003 | 0.515 | Estrogen receptor beta agonist | 0.515 0.003 CID_359 0.096 0.012 CID_152432 | CID_359 | |
| 0.459 | 0.039 | 0.712 | GABA C receptor rho-3 antagonist | 0.712 0.003 CID_359 0.236 0.167 CID_152432 | CID_359 | |
| 0.409 | 0.026 | 0.409 | DNA damaging | 0.323 0.049 CID_359 0.285 0.064 CID_152432 | ||
| 0.381 | 0.004 | 0.381 | AMP-activated protein kinase stimulant | 0.17 0.018 CID_359 0.134 0.039 CID_152432 | ||
| 0.387 | 0.013 | 0.387 | Platelet adhesion inhibitor | 0.262 0.045 CID_359 0.179 0.082 CID_152432 | ||
| 0.387 | 0.024 | 0.387 | Angiogenesis stimulant | 0.364 0.029 CID_359 0.146 0.125 CID_152432 | ||
| 0.359 | 0.006 | 0.359 | Cholesterol synthesis inhibitor | 0.246 0.018 CID_359 0.318 0.01 CID_152432 | ||
| 0.399 | 0.05 | 0.399 | Immunostimulant | 0.312 0.075 CID_359 0.376 0.057 CID_152432 | ||
| 0.407 | 0.06 | 0.467 | Immunosuppressant | 0.317 0.105 CID_359 0.467 0.042 CID_152432 | CID_152432 | |
| 0.35 | 0.005 | 0.386 | Nitric-oxide synthase stimulant | 0.386 0.004 CID_359 0.253 0.03 CID_152432 | CID_359 | |
| 0.376 | 0.031 | 0.376 | Tumour necrosis factor alpha release inhibitor | 0.204 0.105 CID_359 0.22 0.093 CID_152432 | ||
| 0.365 | 0.022 | 0.44 | RNA-directed DNA polymerase inhibitor | 0.44 0.014 CID_359 0.322 0.028 CID_152432 | CID_359 | |
| 0.343 | 0.004 | 0.343 | Protein kinase C zeta inhibitor | 0.157 0.018 CID_359 | ||
| 0.387 | 0.048 | 0.694 | 5 Hydroxytryptamine release stimulant | 0.694 0.007 CID_359 0.173 0.149 CID_152432 | CID_359 | |
| 0.379 | 0.043 | 0.381 | Vasodilator, coronary | 0.381 0.042 CID_359 0.302 0.086 CID_152432 | CID_359 | |
| 0.339 | 0.016 | 0.339 | DNA methyltransferase I inhibitor | 0.298 0.027 CID_359 | ||
| 0.336 | 0.014 | 0.336 | Protein-tyrosine phosphatase inhibitor | 0.313 0.017 CID_359 0.211 0.043 CID_152432 | ||
| 0.326 | 0.009 | 0.326 | Protein-tyrosine phosphatase 1B inhibitor | 0.255 0.016 CID_359 0.118 0.065 CID_152432 | ||
| 0.347 | 0.036 | 0.552 | Hypolipemic | 0.187 0.104 CID_359 0.552 0.009 CID_152432 | CID_152432 | |
| 0.313 | 0.003 | 0.313 | Papain-like protease (SARS coronavirus) inhibitor | 0.191 0.013 CID_359 | ||
| 0.322 | 0.014 | 0.464 | Protein kinase stimulant | 0.296 0.017 CID_359 0.464 0.005 CID_152432 | CID_152432 | |
| 0.327 | 0.021 | 0.327 | DNA methylase inhibitor | 0.286 0.032 CID_359 | ||
| 0.358 | 0.054 | 0.42 | 12-Lipoxygenase inhibitor | 0.42 0.034 CID_359 0.185 0.168 CID_152432 | CID_359 | |
| 0.314 | 0.011 | 0.314 | NADPH oxidase inhibitor | 0.304 0.012 CID_359 0.112 0.094 CID_152432 | ||
| 0.303 | 0.003 | 0.303 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.15 0.007 CID_359 0.075 0.027 CID_152432 | ||
| 0.303 | 0.007 | 0.303 | Xanthine oxidase inhibitor | 0.239 0.013 CID_359 0.138 0.039 CID_152432 | ||
| 0.295 | 0.004 | 0.46 | Estrogen receptor alpha agonist | 0.46 0.003 CID_359 0.097 0.009 CID_152432 | CID_359 | |
| 0.301 | 0.012 | 0.301 | Alkaline phosphatase inhibitor | 0.216 0.028 CID_359 0.2 0.033 CID_152432 | ||
| 0.302 | 0.023 | 0.403 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.403 0.008 CID_359 0.271 0.034 CID_152432 | CID_359 | |
| 0.278 | 0.005 | 0.278 | Protein kinase C mu inhibitor | |||
| 0.283 | 0.015 | 0.283 | Acetylcholinesterase inhibitor | 0.111 0.087 CID_359 | ||
| 0.276 | 0.01 | 0.501 | Interleukin 4 antagonist | 0.501 0.004 CID_359 0.183 0.028 CID_152432 | CID_359 | |
| 0.339 | 0.075 | 0.339 | Angiogenesis inhibitor | 0.286 0.1 CID_359 | ||
| 0.296 | 0.032 | 0.296 | MAP-kinase-activated kinase 5 inhibitor | 0.211 0.09 CID_359 | ||
| 0.334 | 0.071 | 0.543 | Cholesterol antagonist | 0.523 0.029 CID_359 0.543 0.026 CID_152432 | CID_152432 | |
| 0.262 | 0.004 | 0.262 | Lipase inhibitor | 0.137 0.012 CID_359 | ||
| 0.288 | 0.031 | 0.288 | P-glycoprotein inhibitor | 0.209 0.058 CID_359 0.171 0.088 CID_152432 | ||
| 0.257 | 0.004 | 0.257 | Carbonic anhydrase VB inhibitor | 0.18 0.006 CID_359 0.05 0.045 CID_152432 | ||
| 0.255 | 0.006 | 0.255 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.233 0.007 CID_359 0.132 0.024 CID_152432 | ||
| 0.256 | 0.007 | 0.278 | Alcohol dehydrogenase inhibitor | 0.278 0.006 CID_359 | CID_359 | |
| 0.253 | 0.008 | 0.253 | Carbonic anhydrase XIII inhibitor | 0.245 0.009 CID_359 0.149 0.022 CID_152432 | ||
| 0.251 | 0.008 | 0.251 | Beta glucuronidase inhibitor | 0.217 0.011 CID_359 0.164 0.019 CID_152432 | ||
| 0.326 | 0.084 | 0.456 | Vasodilator, peripheral | 0.456 0.039 CID_359 0.26 0.12 CID_152432 | CID_359 | |
| 0.244 | 0.004 | 0.244 | Xanthine dehydrogenase inhibitor | 0.129 0.009 CID_359 | ||
| 0.293 | 0.053 | 0.673 | Superoxide dismutase inhibitor | 0.673 0.005 CID_359 0.217 0.1 CID_152432 | CID_359 | |
| 0.263 | 0.026 | 0.324 | Interferon gamma antagonist | 0.308 0.019 CID_359 0.324 0.017 CID_152432 | CID_152432 | |
| 0.242 | 0.01 | 0.242 | Androgen antagonist | 0.152 0.022 CID_359 0.136 0.026 CID_152432 | ||
| 0.235 | 0.005 | 0.235 | Carbonic anhydrase V inhibitor | 0.173 0.01 CID_359 | ||
| 0.246 | 0.017 | 0.284 | Topoisomerase I inhibitor | 0.284 0.012 CID_359 0.087 0.082 CID_152432 | CID_359 | |
| 0.254 | 0.033 | 0.254 | Thrombolytic | 0.154 0.079 CID_359 | ||
| 0.243 | 0.023 | 0.288 | Cyclooxygenase 1 inhibitor | 0.288 0.015 CID_359 | CID_359 | |
| 0.235 | 0.016 | 0.235 | Antineoplastic antibiotic | 0.131 0.036 CID_359 0.21 0.019 CID_152432 | ||
| 0.224 | 0.004 | 0.224 | Carbonic anhydrase VII inhibitor | 0.089 0.011 CID_359 | ||
| 0.228 | 0.01 | 0.228 | Beta amyloid protein antagonist | 0.157 0.036 CID_359 0.129 0.058 CID_152432 | ||
| 0.235 | 0.018 | 0.379 | 5-Lipoxygenase inhibitor | 0.379 0.006 CID_359 0.189 0.027 CID_152432 | CID_359 | |
| 0.29 | 0.081 | 0.348 | Interleukin 2 agonist | 0.348 0.046 CID_359 0.257 0.111 CID_152432 | CID_359 | |
| 0.262 | 0.054 | 0.296 | Psychostimulant | 0.296 0.044 CID_359 0.139 0.126 CID_152432 | CID_359 | |
| 0.238 | 0.032 | 0.238 | Cholinergic | |||
| 0.21 | 0.004 | 0.21 | Carbonic anhydrase VA inhibitor | 0.155 0.01 CID_359 | ||
| 0.211 | 0.012 | 0.211 | Protein kinase C gamma inhibitor | 0.171 0.022 CID_359 | ||
| 0.205 | 0.011 | 0.205 | Gastric antisecretory | 0.113 0.05 CID_359 | ||
| 0.206 | 0.014 | 0.326 | Topoisomerase II alpha inhibitor | 0.326 0.006 CID_359 | CID_359 | |
| 0.202 | 0.01 | 0.202 | Opioid kappa receptor antagonist | 0.199 0.01 CID_359 | ||
| 0.224 | 0.033 | 0.382 | Succinate dehydrogenase inhibitor | 0.382 0.004 CID_359 0.23 0.03 CID_152432 | CID_359 | |
| 0.197 | 0.007 | 0.297 | DOPA decarboxylase inhibitor | 0.297 0.003 CID_359 0.15 0.021 CID_152432 | CID_359 | |
| 0.283 | 0.095 | 0.391 | Sodium/bile acid cotransporter inhibitor | 0.391 0.02 CID_359 0.288 0.09 CID_152432 | CID_359 | |
| 0.302 | 0.115 | 0.302 | Antiobesity | |||
| 0.2 | 0.014 | 0.2 | Breast cancer-resistant protein inhibitor | 0.194 0.014 CID_359 | ||
| 0.244 | 0.062 | 0.339 | Antimitotic | 0.172 0.102 CID_359 0.339 0.035 CID_152432 | CID_152432 | |
| 0.217 | 0.041 | 0.217 | Protein kinase C nu inhibitor | |||
| 0.319 | 0.144 | 0.627 | 5 Hydroxytryptamine release inhibitor | 0.627 0.008 CID_359 0.391 0.084 CID_152432 | CID_359 | |
| 0.195 | 0.021 | 0.214 | Expectorant | 0.214 0.018 CID_359 0.157 0.032 CID_152432 | CID_359 | |
| 0.189 | 0.016 | 0.218 | Mucolytic | 0.218 0.01 CID_359 0.152 0.031 CID_152432 | CID_359 | |
| 0.203 | 0.03 | 0.235 | Arachidonic acid antagonist | 0.235 0.01 CID_359 0.199 0.034 CID_152432 | CID_359 | |
| 0.197 | 0.026 | 0.197 | Proteasome inhibitor | 0.15 0.047 CID_359 | ||
| 0.197 | 0.026 | 0.197 | DNA intercalator | 0.091 0.084 CID_359 | ||
| 0.198 | 0.028 | 0.198 | Neurotrophic factor | 0.137 0.072 CID_359 | ||
| 0.196 | 0.028 | 0.196 | Alkylator | 0.194 0.028 CID_359 | ||
| 0.221 | 0.054 | 0.243 | Insulin sensitizer | 0.243 0.038 CID_359 0.205 0.068 CID_152432 | CID_359 | |
| 0.179 | 0.013 | 0.179 | Urease inhibitor | 0.17 0.015 CID_359 | ||
| 0.242 | 0.076 | 0.584 | Tyrosine 3 hydroxylase inhibitor | 0.584 0.003 CID_359 0.349 0.016 CID_152432 | CID_359 | |
| 0.166 | 0.003 | 0.166 | Squalene epoxidase inhibitor | 0.096 0.006 CID_359 0.053 0.029 CID_152432 | ||
| 0.168 | 0.011 | 0.27 | Macrophage migration inhibitory factor inhibitor | 0.27 0.005 CID_359 0.121 0.025 CID_152432 | CID_359 | |
| 0.164 | 0.007 | 0.164 | Phosphodiesterase 6D inhibitor | 0.13 0.017 CID_359 0.088 0.08 CID_152432 | ||
| 0.169 | 0.013 | 0.169 | Toll-Like receptor 4 antagonist | 0.164 0.014 CID_359 0.095 0.078 CID_152432 | ||
| 0.208 | 0.052 | 0.269 | Amyloid beta precursor protein antagonist | 0.269 0.026 CID_359 | CID_359 | |
| 0.158 | 0.006 | 0.158 | Transcription factor AP-1 inhibitor | 0.063 0.04 CID_359 0.075 0.025 CID_152432 | ||
| 0.177 | 0.028 | 0.24 | Adenylate cyclase stimulant | 0.24 0.005 CID_359 0.179 0.026 CID_152432 | CID_359 | |
| 0.262 | 0.117 | 0.443 | Antithrombotic | 0.331 0.072 CID_359 0.443 0.039 CID_152432 | CID_152432 | |
| 0.144 | 0.004 | 0.144 | Cholesterol esterase inhibitor | 0.062 0.015 CID_359 | ||
| 0.178 | 0.038 | 0.286 | CF transmembrane conductance regulator agonist | 0.286 0.004 CID_359 | CID_359 | |
| 0.151 | 0.01 | 0.223 | Aldose reductase inhibitor | 0.223 0.006 CID_359 0.076 0.024 CID_152432 | CID_359 | |
| 0.163 | 0.025 | 0.404 | UDP-glucose 4-epimerase inhibitor | 0.404 0.005 CID_359 0.154 0.027 CID_152432 | CID_359 | |
| 0.16 | 0.022 | 0.16 | Protein kinase A inhibitor | |||
| 0.16 | 0.023 | 0.209 | Opioid antagonist | 0.209 0.012 CID_359 | CID_359 | |
| 0.154 | 0.016 | 0.177 | Anabolic | 0.177 0.008 CID_359 0.156 0.015 CID_152432 | CID_359 | |
| 0.15 | 0.014 | 0.302 | HIV-1 integrase (3'-Processing) inhibitor | 0.302 0.005 CID_359 0.122 0.019 CID_152432 | CID_359 | |
| 0.144 | 0.008 | 0.144 | Protein kinase C eta inhibitor | 0.084 0.022 CID_359 | ||
| 0.217 | 0.082 | 0.405 | Cyclic AMP phosphodiesterase inhibitor | 0.349 0.026 CID_359 0.405 0.016 CID_152432 | CID_152432 | |
| 0.152 | 0.02 | 0.152 | Telomerase inhibitor | |||
| 0.152 | 0.021 | 0.259 | Prolactin inhibitor | 0.259 0.004 CID_359 0.097 0.058 CID_152432 | CID_359 | |
| 0.213 | 0.083 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.031 CID_359 0.278 0.034 CID_152432 | CID_359 | |
| 0.175 | 0.046 | 0.383 | GABA C receptor rho-2 antagonist | 0.383 0.004 CID_359 | CID_359 | |
| 0.137 | 0.011 | 0.2 | Alpha tubulin antagonist | 0.2 0.006 CID_359 0.067 0.026 CID_152432 | CID_359 | |
| 0.173 | 0.047 | 0.234 | Tubulin antagonist | 0.234 0.028 CID_359 0.148 0.059 CID_152432 | CID_359 | |
| 0.15 | 0.025 | 0.15 | Multidrug resistance-associated protein 1 inhibitor | 0.14 0.031 CID_359 | ||
| 0.144 | 0.019 | 0.144 | ABCA1 expression enhancer | 0.106 0.043 CID_359 | ||
| 0.177 | 0.052 | 0.202 | Cyclooxygenase inhibitor | 0.202 0.041 CID_359 | CID_359 | |
| 0.147 | 0.023 | 0.546 | Electron transport complex I inhibitor | 0.111 0.061 CID_359 0.546 0.003 CID_152432 | CID_152432 | |
| 0.155 | 0.032 | 0.202 | Ca2+-transporting ATPase inhibitor | 0.202 0.003 CID_359 0.167 0.015 CID_152432 | CID_359 | |
| 0.175 | 0.052 | 0.291 | Heat shock protein 90 antagonist | 0.291 0.011 CID_359 | CID_359 | |
| 0.174 | 0.052 | 0.174 | Insulin secretagoues | 0.155 0.069 CID_359 | ||
| 0.155 | 0.035 | 0.248 | Microtubule formation inhibitor | 0.186 0.023 CID_359 0.248 0.009 CID_152432 | CID_152432 | |
| 0.148 | 0.029 | 0.148 | Mediator release inhibitor | 0.148 0.029 CID_359 | ||
| 0.138 | 0.02 | 0.18 | Opioid mu receptor antagonist | 0.18 0.012 CID_359 | CID_359 | |
| 0.135 | 0.017 | 0.286 | Keratolytic | 0.286 0.004 CID_359 0.09 0.038 CID_152432 | CID_359 | |
| 0.176 | 0.063 | 0.269 | ATPase inhibitor | 0.245 0.015 CID_359 0.269 0.01 CID_152432 | CID_152432 | |
| 0.115 | 0.003 | 0.115 | Arginase inhibitor | 0.07 0.008 CID_359 | ||
| 0.16 | 0.05 | 0.656 | Alpha-N-acetylglucosaminidase inhibitor | 0.656 0.003 CID_359 0.271 0.02 CID_152432 | CID_359 | |
| 0.22 | 0.111 | 0.324 | Transcription factor STAT3 inhibitor | 0.324 0.043 CID_359 0.177 0.168 CID_152432 | CID_359 | |
| 0.22 | 0.112 | 0.344 | Transcription factor STAT inhibitor | 0.344 0.036 CID_359 | CID_359 | |
| 0.123 | 0.016 | 0.275 | HIV-1 integrase (Strand Transfer) inhibitor | 0.275 0.005 CID_359 0.11 0.019 CID_152432 | CID_359 | |
| 0.213 | 0.107 | 0.213 | Cardiotonic | |||
| 0.11 | 0.005 | 0.11 | Transcription factor RelA inhibitor | 0.099 0.007 CID_359 | ||
| 0.127 | 0.024 | 0.199 | Opioid delta receptor antagonist | 0.199 0.011 CID_359 | CID_359 | |
| 0.104 | 0.003 | 0.104 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 CID_359 0.027 0.016 CID_152432 | ||
| 0.123 | 0.021 | 0.14 | Analgesic, opioid | 0.14 0.017 CID_359 | CID_359 | |
| 0.131 | 0.031 | 0.245 | Uric acid excretion stimulant | 0.245 0.008 CID_359 | CID_359 | |
| 0.155 | 0.058 | 0.21 | MAO inhibitor | 0.193 0.043 CID_359 0.21 0.038 CID_152432 | CID_152432 | |
| 0.148 | 0.052 | 0.205 | Heat shock protein 70 antagonist | 0.205 0.005 CID_359 0.153 0.039 CID_152432 | CID_359 | |
| 0.098 | 0.003 | 0.098 | Sodium/glucose cotransporter 2 inhibitor | 0.055 0.005 CID_359 0.029 0.014 CID_152432 | ||
| 0.149 | 0.054 | 0.33 | Farnesoid X receptor antagonist | 0.33 0.005 CID_359 | CID_359 | |
| 0.101 | 0.009 | 0.101 | Opioid kappa receptor agonist | 0.045 0.028 CID_359 0.044 0.029 CID_152432 | ||
| 0.131 | 0.042 | 0.395 | GABA C receptor antagonist | 0.395 0.003 CID_359 | CID_359 | |
| 0.101 | 0.013 | 0.101 | Protein kinase C beta inhibitor | 0.101 0.013 CID_359 0.063 0.062 CID_152432 | ||
| 0.108 | 0.025 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_359 0.107 0.025 CID_152432 | CID_359 | |
| 0.093 | 0.011 | 0.139 | Estradiol 17 beta-dehydrogenase inhibitor | 0.132 0.007 CID_359 0.139 0.007 CID_152432 | CID_152432 | |
| 0.128 | 0.048 | 0.25 | Photosensitizer | 0.25 0.006 CID_359 | CID_359 | |
| 0.082 | 0.004 | 0.082 | Glucose-6-phosphate dehydrogenase inhibitor | 0.041 0.021 CID_359 | ||
| 0.101 | 0.023 | 0.101 | Viral attachment inhibitor | |||
| 0.095 | 0.017 | 0.11 | Neuraminidase inhibitor | 0.11 0.012 CID_359 | CID_359 | |
| 0.145 | 0.069 | 0.275 | Mannose-6-phosphate isomerase inhibitor | 0.275 0.008 CID_359 0.123 0.096 CID_152432 | CID_359 | |
| 0.109 | 0.035 | 0.137 | Ornithine decarboxylase inhibitor | 0.137 0.016 CID_359 0.098 0.046 CID_152432 | CID_359 | |
| 0.132 | 0.06 | 0.358 | Aldehyde dehydrogenase inhibitor | 0.358 0.007 CID_359 0.11 0.083 CID_152432 | CID_359 | |
| 0.122 | 0.052 | 0.493 | Chelator | 0.493 0.005 CID_359 0.126 0.048 CID_152432 | CID_359 | |
| 0.159 | 0.089 | 0.336 | Phospholipase C inhibitor | 0.336 0.015 CID_359 0.195 0.047 CID_152432 | CID_359 | |
| 0.113 | 0.044 | 0.252 | HIV-1 integrase (Overall Integration) inhibitor | 0.252 0.005 CID_359 0.147 0.026 CID_152432 | CID_359 | |
| 0.098 | 0.031 | 0.196 | D-Ala-D-Ala ligase inhibitor | 0.196 0.003 CID_359 0.077 0.076 CID_152432 | CID_359 | |
| 0.091 | 0.024 | 0.13 | MAP kinase kinase 7 inhibitor | 0.13 0.004 CID_359 0.076 0.058 CID_152432 | CID_359 | |
| 0.113 | 0.046 | 0.303 | GABA C receptor rho-1 antagonist | 0.303 0.003 CID_359 | CID_359 | |
| 0.107 | 0.041 | 0.186 | Thioredoxin inhibitor | 0.186 0.01 CID_359 | CID_359 | |
| 0.073 | 0.008 | 0.182 | Dopamine D5 agonist | 0.182 0.002 CID_359 0.061 0.011 CID_152432 | CID_359 | |
| 0.104 | 0.039 | 0.333 | NADH dehydrogenase inhibitor | 0.333 0.006 CID_359 0.111 0.034 CID_152432 | CID_359 | |
| 0.13 | 0.07 | 0.139 | Cyclooxygenase 2 inhibitor | 0.139 0.063 CID_359 | CID_359 | |
| 0.073 | 0.014 | 0.073 | Prolyl endopeptidase inhibitor | 0.059 0.025 CID_359 | ||
| 0.127 | 0.07 | 0.23 | Toll-Like receptor 2 antagonist | 0.23 0.013 CID_359 0.185 0.031 CID_152432 | CID_359 | |
| 0.177 | 0.12 | 0.204 | Platelet antagonist | 0.204 0.098 CID_152432 | CID_152432 | |
| 0.086 | 0.029 | 0.086 | Secretase beta inhibitor | 0.083 0.032 CID_359 | ||
| 0.06 | 0.004 | 0.14 | Estrogen-related receptor beta antagonist | 0.14 0.002 CID_359 | CID_359 | |
| 0.087 | 0.031 | 0.202 | Glycine receptor agonist | 0.202 0.004 CID_359 0.077 0.042 CID_152432 | CID_359 | |
| 0.059 | 0.006 | 0.081 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.081 0.004 CID_359 0.021 0.017 CID_152432 | CID_359 | |
| 0.075 | 0.023 | 0.1 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.1 0.01 CID_359 | CID_359 | |
| 0.073 | 0.022 | 0.103 | Opioid agonist | 0.103 0.013 CID_359 | CID_359 | |
| 0.098 | 0.049 | 0.183 | Antineoplastic alkaloid | 0.148 0.028 CID_359 0.183 0.019 CID_152432 | CID_152432 | |
| 0.068 | 0.021 | 0.117 | Opioid mu receptor agonist | 0.117 0.01 CID_359 | CID_359 | |
| 0.137 | 0.093 | 0.196 | MAP kinase kinase 4 inhibitor | 0.196 0.015 CID_359 | CID_359 | |
| 0.181 | 0.138 | 0.359 | Interleukin agonist | 0.359 0.027 CID_359 0.24 0.087 CID_152432 | CID_359 | |
| 0.071 | 0.028 | 0.856 | Alcohol oxidase inhibitor | 0.856 0.002 CID_359 0.073 0.027 CID_152432 | CID_359 | |
| 0.147 | 0.104 | 0.213 | Tumour necrosis factor antagonist | 0.213 0.046 CID_359 | CID_359 | |
| 0.051 | 0.009 | 0.142 | Catechol O-methyltransferase inhibitor | 0.142 0.004 CID_359 0.039 0.015 CID_152432 | CID_359 | |
| 0.073 | 0.032 | 0.138 | Neuraminidase (influenza) inhibitor | 0.138 0.009 CID_359 0.066 0.041 CID_152432 | CID_359 | |
| 0.1 | 0.059 | 0.148 | MAO B inhibitor | 0.148 0.038 CID_359 0.12 0.05 CID_152432 | CID_359 | |
| 0.101 | 0.063 | 0.146 | Bronchodilator | 0.146 0.033 CID_359 | CID_359 | |
| 0.061 | 0.023 | 0.082 | Glucose-6-phosphate translocase inhibitor | 0.082 0.01 CID_359 | CID_359 | |
| 0.068 | 0.032 | 0.109 | Androgen agonist | 0.109 0.012 CID_359 0.066 0.034 CID_152432 | CID_359 | |
| 0.059 | 0.024 | 0.063 | Plasminogen activator inhibitor antagonist | 0.063 0.022 CID_359 | CID_359 | |
| 0.22 | 0.185 | 0.434 | Calcium channel activator | 0.434 0.014 CID_359 0.332 0.062 CID_152432 | CID_359 | |
| 0.077 | 0.043 | 0.254 | Phosphofructokinase-1 inhibitor | 0.254 0.007 CID_359 0.201 0.011 CID_152432 | CID_359 | |
| 0.052 | 0.019 | 0.052 | HIV-1 protease inhibitor | |||
| 0.058 | 0.025 | 0.065 | Vanilloid 2 antagonist | 0.065 0.018 CID_359 0.052 0.037 CID_152432 | CID_359 | |
| 0.078 | 0.045 | 0.087 | Phosphodiesterase VI inhibitor | 0.087 0.031 CID_359 | CID_359 | |
| 0.068 | 0.035 | 0.068 | Nitric oxide donor | |||
| 0.139 | 0.107 | 0.322 | Interleukin 6 antagonist | 0.228 0.028 CID_359 0.322 0.012 CID_152432 | CID_152432 | |
| 0.043 | 0.011 | 0.088 | ATP citrate lysase inhibitor | 0.082 0.004 CID_359 0.088 0.004 CID_152432 | CID_152432 | |
| 0.097 | 0.066 | 0.186 | MAO A inhibitor | 0.186 0.032 CID_359 0.135 0.046 CID_152432 | CID_359 | |
| 0.067 | 0.036 | 0.177 | Beta tubulin antagonist | 0.177 0.009 CID_359 | CID_359 | |
| 0.056 | 0.026 | 0.136 | Topoisomerase II beta inhibitor | 0.136 0.005 CID_359 0.054 0.027 CID_152432 | CID_359 | |
| 0.083 | 0.053 | 0.135 | Glycine receptor antagonist | 0.135 0.011 CID_359 0.075 0.066 CID_152432 | CID_359 | |
| 0.051 | 0.022 | 0.051 | Cathepsin L2 inhibitor | |||
| 0.088 | 0.059 | 0.152 | ATPase (Vacuolar H+) inhibitor | 0.084 0.069 CID_359 0.152 0.007 CID_152432 | CID_152432 | |
| 0.084 | 0.055 | 0.169 | Estrogen-related receptor beta agonist | 0.169 0.003 CID_359 0.092 0.037 CID_152432 | CID_359 | |
| 0.061 | 0.033 | 0.061 | Lipocortins synthesis agonist | 0.058 0.039 CID_359 | ||
| 0.059 | 0.031 | 0.178 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.178 0.004 CID_359 0.05 0.042 CID_152432 | CID_359 | |
| 0.123 | 0.095 | 0.246 | Cell wall synthesis inhibitor | 0.246 0.017 CID_359 0.196 0.032 CID_152432 | CID_359 | |
| 0.068 | 0.041 | 0.1 | Dopamine D1 antagonist | 0.1 0.025 CID_359 | CID_359 | |
| 0.075 | 0.049 | 0.225 | Histone deacetylase stimulant | 0.225 0.005 CID_359 | CID_359 | |
| 0.075 | 0.049 | 0.225 | Histone deacetylase SIRT1 stimulant | 0.225 0.005 CID_359 | CID_359 | |
| 0.127 | 0.101 | 0.181 | Hemostatic | 0.181 0.041 CID_359 0.156 0.061 CID_152432 | CID_359 | |
| 0.04 | 0.015 | 0.081 | Tubulin agonist | 0.036 0.021 CID_359 0.081 0.003 CID_152432 | CID_152432 | |
| 0.051 | 0.026 | 0.063 | Microtubule stabilization | 0.063 0.011 CID_152432 | CID_152432 | |
| 0.104 | 0.079 | 0.116 | Nav1.5 sodium channel blocker | 0.116 0.06 CID_359 | CID_359 | |
| 0.124 | 0.1 | 0.173 | Diuretic | 0.173 0.058 CID_359 0.158 0.07 CID_152432 | CID_359 | |
| 0.066 | 0.041 | 0.066 | DNA gyrase inhibitor | |||
| 0.066 | 0.044 | 0.084 | Leukotriene antagonist | 0.084 0.029 CID_359 0.084 0.029 CID_152432 | CID_152432 | |
| 0.07 | 0.048 | 0.195 | HIV-1 integrase inhibitor | 0.195 0.005 CID_359 0.147 0.009 CID_152432 | CID_359 | |
| 0.091 | 0.069 | 0.091 | Butyrylcholinesterase inhibitor | |||
| 0.068 | 0.046 | 0.108 | Dopamine agonist | 0.089 0.032 CID_359 0.108 0.024 CID_152432 | CID_152432 | |
| 0.042 | 0.02 | 0.268 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.268 0.003 CID_359 0.04 0.021 CID_152432 | CID_359 | |
| 0.066 | 0.044 | 0.066 | Glucagon-like peptide 1 agonist | |||
| 0.03 | 0.009 | 0.059 | Dopamine D1 agonist | 0.039 0.005 CID_359 0.059 0.004 CID_152432 | CID_152432 | |
| 0.072 | 0.055 | 0.072 | Alpha 2a adrenoreceptor antagonist | |||
| 0.069 | 0.056 | 0.364 | Glutamate decarboxylase inhibitor | 0.364 0.003 CID_359 0.117 0.022 CID_152432 | CID_359 | |
| 0.052 | 0.039 | 0.07 | Leukotriene B4 antagonist | 0.07 0.02 CID_359 0.07 0.019 CID_152432 | CID_152432 | |
| 0.047 | 0.034 | 0.126 | Glucose-6-phosphate isomerase inhibitor | 0.126 0.003 CID_359 0.069 0.013 CID_152432 | CID_359 | |
| 0.032 | 0.02 | 0.032 | RNA-directed RNA polymerase stimulant | 0.026 0.024 CID_152432 | ||
| 0.151 | 0.139 | 0.226 | Histone acetyltransferase inhibitor | 0.226 0.039 CID_359 | CID_359 | |
| 0.069 | 0.058 | 0.188 | CDC25A inhibitor | 0.188 0.008 CID_359 0.14 0.014 CID_152432 | CID_359 | |
| 0.174 | 0.163 | 0.361 | DNA synthesis inhibitor | 0.361 0.028 CID_359 0.25 0.066 CID_152432 | CID_359 | |
| 0.064 | 0.054 | 0.122 | Glutamate (mGluR7) antagonist | 0.122 0.004 CID_359 | CID_359 | |
| 0.136 | 0.128 | 0.179 | Lipocortins synthesis antagonist | 0.179 0.072 CID_359 | CID_359 | |
| 0.056 | 0.047 | 0.101 | Sphingosine kinase inhibitor | 0.101 0.007 CID_359 | CID_359 | |
| 0.035 | 0.027 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.025 CID_152432 | CID_152432 | |
| 0.03 | 0.024 | 0.03 | Glucocorticoid antagonist | |||
| 0.046 | 0.04 | 0.047 | HCV NS3/NS4A protease inhibitor | 0.047 0.038 CID_359 | CID_359 | |
| 0.077 | 0.071 | 0.077 | Alpha 2 adrenoreceptor antagonist | |||
| 0.108 | 0.103 | 0.167 | Antibacterial (Helicobacter pylori) | 0.167 0.035 CID_359 | CID_359 | |
| 0.138 | 0.134 | 0.232 | Non-steroidal antiinflammatory agent | 0.232 0.051 CID_359 0.207 0.065 CID_152432 | CID_359 | |
| 0.059 | 0.055 | 0.082 | Beta 2 adrenoreceptor agonist | 0.082 0.008 CID_359 | CID_359 | |
| 0.038 | 0.035 | 0.057 | Carbonic anhydrase IV inhibitor | 0.057 0.021 CID_359 | CID_359 | |
| 0.018 | 0.015 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 CID_359 | CID_359 | |
| 0.027 | 0.024 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_359 | CID_359 | |
| 0.032 | 0.03 | 0.057 | Opioid delta receptor agonist | 0.057 0.01 CID_359 | CID_359 | |
| 0.12 | 0.117 | 0.214 | Phospholipase A2 inhibitor | 0.193 0.047 CID_359 0.214 0.036 CID_152432 | CID_152432 | |
| 0.044 | 0.041 | 0.106 | Carbonic anhydrase XIV inhibitor | 0.106 0.009 CID_359 0.05 0.032 CID_152432 | CID_359 | |
| 0.059 | 0.057 | 0.121 | Leukotriene synthesis inhibitor | 0.121 0.016 CID_359 0.108 0.022 CID_152432 | CID_359 | |
| 0.138 | 0.136 | 0.248 | Neurotensin receptor agonist | 0.248 0.021 CID_359 | CID_359 | |
| 0.086 | 0.085 | 0.137 | Bile acid receptor antagonist | 0.137 0.01 CID_359 0.1 0.048 CID_152432 | CID_359 | |
| 0.02 | 0.02 | 0.045 | Prostaglandin F2 alpha agonist | 0.045 0.005 CID_359 0.021 0.018 CID_152432 | CID_359 | |
| 0.111 | 0.112 | 0.191 | Vanilloid 1 agonist | 0.181 0.018 CID_359 0.191 0.014 CID_152432 | CID_152432 | |
| 0.055 | 0.056 | 0.094 | Ryanodine receptor antagonist | 0.094 0.005 CID_359 0.074 0.013 CID_152432 | CID_359 | |
| 0.035 | 0.039 | 0.073 | Dopamine D2 agonist | 0.073 0.016 CID_359 0.064 0.019 CID_152432 | CID_359 | |
| 0.003 | 0.008 | 0.007 | Transcortin receptor antagonist | 0.007 0.003 CID_359 | CID_359 | |
| 0.048 | 0.053 | 0.119 | Sphingosine kinase 2 inhibitor | 0.119 0.005 CID_359 | CID_359 | |
| 0.011 | 0.019 | 0.026 | NMDA receptor phencyclidine site antagonist | 0.026 0.005 CID_359 | CID_359 | |
| 0.051 | 0.059 | 0.075 | Selectin antagonist | 0.075 0.039 CID_359 | CID_359 | |
| 0.016 | 0.025 | 0.02 | Estrone sulfatase inhibitor | 0.02 0.017 CID_359 | CID_359 | |
| 0.013 | 0.023 | 0.018 | Antibiotic Tetracycline-like | 0.018 0.005 CID_359 | CID_359 | |
| 0.028 | 0.038 | 0.045 | 5-Alpha-reductase inhibitor | 0.045 0.021 CID_359 | CID_359 | |
| 0.051 | 0.062 | 0.071 | Leukotriene C antagonist | 0.071 0.013 CID_359 0.053 0.049 CID_152432 | CID_359 | |
| 0.013 | 0.025 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_359 0.017 0.011 CID_152432 | CID_359 | |
| 0.076 | 0.088 | 0.158 | Granulocyte macrophage colony stimulating factor agonist | 0.158 0.005 CID_359 0.104 0.029 CID_152432 | CID_359 | |
| 0.021 | 0.033 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_359 0.026 0.016 CID_152432 | CID_359 | |
| 0.016 | 0.029 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_359 | CID_359 | |
| 0.071 | 0.084 | 0.171 | Myeloperoxidase inhibitor | 0.171 0.008 CID_359 | CID_359 | |
| 0.123 | 0.137 | 0.162 | Antipruritic | 0.162 0.081 CID_359 | CID_359 | |
| 0.003 | 0.017 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 CID_359 0.006 0.004 CID_152432 | CID_152432 | |
| 0.072 | 0.089 | 0.112 | Thioredoxin reductase inhibitor | 0.112 0.02 CID_359 | CID_359 | |
| 0.059 | 0.076 | 0.227 | Glutamate dehydrogenase inhibitor | 0.227 0.008 CID_359 0.076 0.049 CID_152432 | CID_359 | |
| 0.058 | 0.075 | 0.115 | Glutamate (mGluR6) antagonist | 0.115 0.006 CID_359 | CID_359 | |
| 0.073 | 0.091 | 0.333 | Triose-phosphate isomerase inhibitor | 0.333 0.004 CID_359 0.159 0.018 CID_152432 | CID_359 | |
| 0.005 | 0.022 | 0.011 | Progesterone receptor A antagonist | 0.011 0.005 CID_359 | CID_359 | |
| 0.023 | 0.041 | 0.032 | Progesterone antagonist | 0.032 0.027 CID_359 | CID_359 | |
| 0.045 | 0.064 | 0.215 | Carbamoyl phosphate synthetase inhibitor | 0.215 0.007 CID_359 0.07 0.034 CID_152432 | CID_359 | |
| 0.052 | 0.071 | 0.351 | Phenylalanine 4-hydroxylase inhibitor | 0.351 0.003 CID_359 0.208 0.006 CID_152432 | CID_359 | |
| 0.131 | 0.151 | 0.361 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.361 0.033 CID_359 | CID_359 | |
| 0.094 | 0.114 | 0.248 | Bone formation stimulant | 0.248 0.025 CID_359 0.12 0.085 CID_152432 | CID_359 | |
| 0.047 | 0.067 | 0.056 | Acetyl-CoA transferase 2 inhibitor | 0.056 0.041 CID_152432 | CID_152432 | |
| 0.124 | 0.146 | 0.403 | Anesthetic general | 0.403 0.016 CID_359 0.218 0.065 CID_152432 | CID_359 | |
| 0.096 | 0.12 | 0.176 | Transcription factor STAT6 inhibitor | 0.176 0.011 CID_359 | CID_359 | |
| 0.022 | 0.045 | 0.079 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.071 0.006 CID_359 0.079 0.005 CID_152432 | CID_152432 | |
| 0.042 | 0.067 | 0.177 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.177 0.007 CID_359 | CID_359 | |
| 0.059 | 0.085 | 0.086 | MDM2 inhibitor | 0.086 0.014 CID_359 | CID_359 | |
| 0.049 | 0.075 | 0.137 | CDC25B inhibitor | 0.137 0.008 CID_359 0.077 0.031 CID_152432 | CID_359 | |
| 0.01 | 0.037 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 CID_359 | CID_359 | |
| 0.036 | 0.063 | 0.144 | Protein 50S ribosomal subunit inhibitor | 0.144 0.007 CID_152432 | CID_152432 | |
| 0.015 | 0.043 | 0.048 | Leukotriene B4 receptor 1 antagonist | 0.048 0.008 CID_359 0.031 0.017 CID_152432 | CID_359 | |
| 0.026 | 0.056 | 0.066 | Protein kinase (CK2) beta inhibitor | 0.066 0.005 CID_359 | CID_359 | |
| 0.024 | 0.054 | 0.064 | HMG CoA reductase inhibitor | 0.064 0.004 CID_152432 | CID_152432 | |
| 0.033 | 0.063 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 CID_359 | CID_359 | |
| 0.021 | 0.053 | 0.051 | Retinoid X alpha receptor agonist | 0.051 0.014 CID_359 | CID_359 | |
| 0.115 | 0.147 | 0.447 | Dual specificity phosphatase inhibitor | 0.358 0.02 CID_359 0.447 0.01 CID_152432 | CID_152432 | |
| 0.099 | 0.131 | 0.157 | DNA repair enzyme inhibitor | 0.157 0.025 CID_359 | CID_359 | |
| 0.021 | 0.054 | 0.038 | Hedgehog signaling activator | 0.038 0.005 CID_359 | CID_359 | |
| 0.07 | 0.103 | 0.298 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.298 0.006 CID_359 0.116 0.041 CID_152432 | CID_359 | |
| 0.027 | 0.06 | 0.068 | Carbonic anhydrase XII inhibitor | 0.068 0.03 CID_359 | CID_359 | |
| 0.046 | 0.079 | 0.163 | Heat shock protein 90 beta antagonist | 0.163 0.004 CID_359 0.058 0.044 CID_152432 | CID_359 | |
| 0.033 | 0.068 | 0.082 | DNA gyrase subunit A inhibitor | 0.082 0.005 CID_359 | CID_359 | |
| 0.003 | 0.039 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_152432 | CID_152432 | |
| 0.031 | 0.068 | 0.047 | Leukotriene C4 antagonist | 0.047 0.013 CID_359 | CID_359 | |
| 0.006 | 0.042 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_359 | CID_359 | |
| 0.038 | 0.076 | 0.098 | Alpha-mannosidase inhibitor | 0.098 0.007 CID_359 0.058 0.03 CID_152432 | CID_359 | |
| 0.005 | 0.042 | 0.023 | Glutamate (mGluR6) agonist | 0.023 0.004 CID_359 | CID_359 | |
| 0.085 | 0.123 | 0.196 | TRPA1 agonist | 0.196 0.011 CID_359 0.113 0.068 CID_152432 | CID_359 | |
| 0.108 | 0.146 | 0.32 | Dual specificity phosphatase 3 inhibitor | 0.32 0.025 CID_359 0.251 0.04 CID_152432 | CID_359 | |
| 0.013 | 0.051 | 0.06 | Uridine phosphorylase inhibitor | 0.06 0.005 CID_359 0.05 0.008 CID_152432 | CID_359 | |
| 0.028 | 0.068 | 0.078 | Glutamate (mGluR8) agonist | 0.078 0.004 CID_359 | CID_359 | |
| 0.019 | 0.06 | 0.069 | Estrogen-related receptor alpha antagonist | 0.069 0.009 CID_359 | CID_359 | |
| 0.017 | 0.058 | 0.046 | Thyroid hormone agonist | 0.046 0.005 CID_359 | CID_359 | |
| 0.079 | 0.12 | 0.295 | Adenylate kinase inhibitor | 0.295 0.007 CID_359 0.102 0.064 CID_152432 | CID_359 | |
| 0.109 | 0.152 | 0.298 | Heat shock protein 90 alpha antagonist | 0.298 0.015 CID_359 | CID_359 | |
| 0.05 | 0.094 | 0.077 | Heme oxygenase stimulant | 0.077 0.017 CID_359 | CID_359 | |
| 0.025 | 0.07 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 CID_359 | CID_359 | |
| 0.113 | 0.157 | 0.382 | Pyruvate kinase inhibitor | 0.382 0.024 CID_359 | CID_359 | |
| 0.007 | 0.054 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.014 CID_359 | CID_359 | |
| 0.042 | 0.089 | 0.166 | Purinergic P2X1 antagonist | 0.166 0.005 CID_359 0.078 0.026 CID_152432 | CID_359 | |
| 0.069 | 0.116 | 0.131 | Vanilloid agonist | 0.131 0.014 CID_359 0.127 0.016 CID_152432 | CID_359 | |
| 0.032 | 0.08 | 0.06 | CF transmembrane conductance regulator antagonist | 0.06 0.004 CID_359 | CID_359 | |
| 0.013 | 0.062 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_359 | CID_359 | |
| 0.046 | 0.096 | 0.1 | Aryl hydrocarbon receptor antagonist | 0.1 0.013 CID_359 | CID_359 | |
| 0.008 | 0.058 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 CID_359 | CID_359 | |
| 0.068 | 0.119 | 0.584 | GABA C receptor agonist | 0.584 0.003 CID_359 0.134 0.041 CID_152432 | CID_359 | |
| 0.02 | 0.072 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | 0.037 0.024 CID_359 | CID_359 | |
| 0.069 | 0.121 | 0.13 | CC chemokine 5 receptor agonist | 0.13 0.005 CID_359 | CID_359 | |
| 0.037 | 0.09 | 0.094 | CD45 antagonist | 0.094 0.01 CID_359 | CID_359 | |
| 0.006 | 0.059 | 0.027 | Ileal bile acid transport inhibitor | 0.027 0.005 CID_359 | CID_359 | |
| 0.019 | 0.072 | 0.048 | Dopamine D5 antagonist | 0.048 0.026 CID_359 | CID_359 | |
| 0.023 | 0.078 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 CID_359 | CID_359 | |
| 0.014 | 0.069 | 0.052 | Retinoid X receptor agonist | 0.052 0.017 CID_359 | CID_359 | |
| 0.017 | 0.072 | 0.03 | Cholesterol ester transfer protein antagonist | 0.03 0.023 CID_359 | CID_359 | |
| 0.026 | 0.081 | 0.089 | Mannosidase inhibitor | 0.089 0.007 CID_359 0.046 0.03 CID_152432 | CID_359 | |
| 0.003 | 0.059 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 CID_359 | CID_359 | |
| 0.065 | 0.122 | 0.119 | mTOR complex 2 inhibitor | 0.119 0.018 CID_359 | CID_359 | |
| 0.051 | 0.108 | 0.076 | Metalloproteinase-2 inhibitor | 0.076 0.056 CID_359 | CID_359 | |
| 0.035 | 0.093 | 0.056 | Beta adrenoreceptor agonist | 0.056 0.011 CID_359 0.043 0.039 CID_152432 | CID_359 | |
| 0.016 | 0.074 | 0.105 | Fumarate hydratase inhibitor | 0.105 0.005 CID_359 | CID_359 | |
| 0.012 | 0.071 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 CID_359 | CID_359 | |
| 0.022 | 0.08 | 0.055 | Glutamate (mGluR3) agonist | 0.055 0.004 CID_359 | CID_359 | |
| 0.026 | 0.086 | 0.061 | Sphingosine kinase 1 inhibitor | 0.061 0.009 CID_359 | CID_359 | |
| 0.042 | 0.104 | 0.15 | Cyclin B3 inhibitor | 0.15 0.014 CID_359 | CID_359 | |
| 0.013 | 0.075 | 0.033 | Prostaglandin agonist | 0.033 0.019 CID_359 | CID_359 | |
| 0.052 | 0.115 | 0.145 | Adrenaline agonist | 0.145 0.016 CID_359 0.073 0.068 CID_152432 | CID_359 | |
| 0.028 | 0.094 | 0.071 | Kainate receptor agonist | 0.071 0.004 CID_359 | CID_359 | |
| 0.016 | 0.083 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 CID_359 | CID_359 | |
| 0.03 | 0.097 | 0.075 | Purinergic P2X4 antagonist | 0.075 0.008 CID_359 | CID_359 | |
| 0.003 | 0.074 | 0.012 | Thromboxane agonist | 0.012 0.006 CID_359 | CID_359 | |
| 0.177 | 0.248 | 0.273 | DNA directed DNA polymerase inhibitor | 0.273 0.177 CID_359 | CID_359 | |
| 0.012 | 0.084 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.005 CID_359 | CID_359 | |
| 0.028 | 0.101 | 0.187 | Argininosuccinate synthase inhibitor | 0.187 0.008 CID_359 0.049 0.048 CID_152432 | CID_359 | |
| 0.057 | 0.13 | 0.124 | Glutathione S-transferase inhibitor | 0.124 0.021 CID_359 | CID_359 | |
| 0.066 | 0.139 | 0.187 | Adenylate cyclase inhibitor | 0.187 0.028 CID_359 0.104 0.081 CID_152432 | CID_359 | |
| 0.049 | 0.123 | 0.074 | Metalloproteinase-9 inhibitor | 0.074 0.05 CID_359 | CID_359 | |
| 0.027 | 0.1 | 0.183 | Acyl-CoA dehydrogenase inhibitor | 0.183 0.006 CID_359 | CID_359 | |
| 0.12 | 0.194 | 0.192 | Death-associated protein kinase 2 inhibitor | 0.192 0.041 CID_359 | CID_359 | |
| 0.022 | 0.096 | 0.059 | Liver X receptor alpha agonist | 0.059 0.013 CID_359 | CID_359 | |
| 0.039 | 0.114 | 0.102 | Beta adrenoreceptor antagonist | 0.102 0.015 CID_359 | CID_359 | |
| 0.027 | 0.101 | 0.101 | Adenylate cyclase 1 inhibitor | 0.101 0.004 CID_359 | CID_359 | |
| 0.014 | 0.09 | 0.069 | Phosphoglycerate kinase inhibitor | 0.069 0.01 CID_359 | CID_359 | |
| 0.045 | 0.121 | 0.143 | CYP2A6 inhibitor | 0.143 0.018 CID_359 | CID_359 | |
| 0.028 | 0.104 | 0.07 | GABA B receptor antagonist | 0.07 0.009 CID_359 | CID_359 | |
| 0.011 | 0.088 | 0.033 | CYP24 inhibitor | 0.033 0.009 CID_359 | CID_359 | |
| 0.112 | 0.19 | 0.326 | Dyrk kinase inhibitor | 0.326 0.044 CID_359 | CID_359 | |
| 0.069 | 0.147 | 0.159 | Glutamate release inhibitor | 0.159 0.008 CID_359 | CID_359 | |
| 0.061 | 0.139 | 0.092 | Alpha 2c adrenoreceptor antagonist | 0.092 0.073 CID_359 | CID_359 | |
| 0.056 | 0.137 | 0.156 | Sphingomyelinase inhibitor | 0.156 0.022 CID_359 | CID_359 | |
| 0.004 | 0.085 | 0.016 | Adenosine A2a receptor agonist | 0.016 0.01 CID_359 | CID_359 | |
| 0.03 | 0.11 | 0.165 | Aconitate hydratase inhibitor | 0.165 0.004 CID_359 0.053 0.034 CID_152432 | CID_359 | |
| 0.008 | 0.088 | 0.016 | Vitamin D receptor agonist | 0.016 0.014 CID_359 | CID_359 | |
| 0.007 | 0.088 | 0.034 | Dopamine autoreceptor agonist | 0.034 0.012 CID_359 | CID_359 | |
| 0.026 | 0.108 | 0.081 | Beta 2 adrenoreceptor antagonist | 0.081 0.011 CID_359 | CID_359 | |
| 0.007 | 0.089 | 0.026 | Thyroid hormone alpha antagonist | 0.026 0.005 CID_359 | CID_359 | |
| 0.018 | 0.102 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.033 0.008 CID_359 | CID_359 | |
| 0.019 | 0.104 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 CID_359 | CID_359 | |
| 0.026 | 0.112 | 0.05 | Vanilloid 3 antagonist | 0.05 0.008 CID_359 | CID_359 | |
| 0.039 | 0.126 | 0.089 | Pregnane X receptor antagonist | 0.089 0.004 CID_359 0.06 0.03 CID_152432 | CID_359 | |
| 0.007 | 0.094 | 0.028 | Prostaglandin EP2 agonist | 0.028 0.013 CID_359 | CID_359 | |
| 0.026 | 0.116 | 0.126 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.126 0.002 CID_359 0.04 0.032 CID_152432 | CID_359 | |
| 0.055 | 0.146 | 0.122 | Aminoacyl-tRNA synthetase inhibitor | 0.122 0.029 CID_359 | CID_359 | |
| 0.043 | 0.135 | 0.106 | Beta 3 adrenoreceptor antagonist | 0.106 0.013 CID_359 | CID_359 | |
| 0.019 | 0.113 | 0.066 | Potassium channel Kv1.3 blocker | 0.066 0.018 CID_359 0.048 0.031 CID_152432 | CID_359 | |
| 0.005 | 0.101 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 CID_359 | CID_359 | |
| 0.018 | 0.115 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.031 CID_359 | CID_359 | |
| 0.006 | 0.103 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 CID_359 | CID_359 | |
| 0.038 | 0.137 | 0.159 | Aminopeptidase I inhibitor | 0.159 0.011 CID_359 | CID_359 | |
| 0.011 | 0.11 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 CID_359 | CID_359 | |
| 0.121 | 0.22 | 0.169 | Growth factor agonist | 0.169 0.103 CID_359 | CID_359 | |
| 0.016 | 0.116 | 0.056 | Estrogen-related receptor gamma antagonist | 0.056 0.003 CID_359 | CID_359 | |
| 0.027 | 0.127 | 0.212 | Biliverdin reductase inhibitor | 0.212 0.005 CID_359 0.066 0.035 CID_152432 | CID_359 | |
| 0.016 | 0.117 | 0.073 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.027 CID_359 | CID_359 | |
| 0.016 | 0.117 | 0.075 | Ribonucleotide reductase inhibitor | 0.075 0.029 CID_359 | CID_359 | |
| 0.018 | 0.119 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 CID_359 | CID_359 | |
| 0.005 | 0.107 | 0.022 | Prostaglandin E2 agonist | 0.022 0.018 CID_359 | CID_359 | |
| 0.053 | 0.155 | 0.169 | GABA B receptor agonist | 0.169 0.004 CID_359 0.072 0.063 CID_152432 | CID_359 | |
| 0.08 | 0.184 | 0.165 | Acetylcholine M1 receptor antagonist | 0.165 0.062 CID_359 | CID_359 | |
| 0.033 | 0.138 | 0.117 | Dihydroorotate oxidase inhibitor | 0.117 0.004 CID_359 0.053 0.042 CID_152432 | CID_359 | |
| 0.006 | 0.111 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 CID_359 | CID_359 | |
| 0.023 | 0.129 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.074 0.012 CID_359 | CID_359 | |
| 0.014 | 0.12 | 0.12 | NMDA receptor subunit 3A antagonist | 0.12 0.007 CID_359 | CID_359 | |
| 0.007 | 0.115 | 0.02 | Thyroid hormone alpha agonist | 0.02 0.007 CID_359 | CID_359 | |
| 0.024 | 0.132 | 0.047 | mTOR inhibitor | 0.047 0.043 CID_359 | CID_359 | |
| 0.009 | 0.117 | 0.027 | Beta 1 adrenoreceptor agonist | 0.027 0.011 CID_359 | CID_359 | |
| 0.028 | 0.136 | 0.084 | Peroxisome proliferator-activated receptor gamma agonist | 0.084 0.038 CID_152432 | CID_152432 | |
| 0.015 | 0.125 | 0.067 | Oxytocin agonist | 0.067 0.011 CID_359 | CID_359 | |
| 0.023 | 0.132 | 0.131 | Maillard reaction inhibitor | 0.131 0.008 CID_359 | CID_359 | |
| 0.005 | 0.115 | 0.041 | Nicotinic acid receptor 1 antagonist | 0.041 0.003 CID_359 | CID_359 | |
| 0.019 | 0.129 | 0.08 | Carbonic anhydrase inhibitor | 0.08 0.035 CID_359 | CID_359 | |
| 0.033 | 0.144 | 0.09 | Glucosylceramidase inhibitor | 0.09 0.011 CID_359 | CID_359 | |
| 0.012 | 0.125 | 0.038 | Farnesoid X receptor agonist | 0.038 0.026 CID_359 | CID_359 | |
| 0.057 | 0.172 | 0.154 | Lanosterol 14 alpha demethylase inhibitor | 0.154 0.01 CID_359 0.109 0.043 CID_152432 | CID_359 | |
| 0.084 | 0.2 | 0.294 | Hexokinase inhibitor | 0.294 0.011 CID_359 | CID_359 | |
| 0.022 | 0.138 | 0.058 | Thymidine kinase inhibitor | 0.058 0.014 CID_359 | CID_359 | |
| 0.004 | 0.12 | 0.028 | Prostaglandin H2 antagonist | 0.028 0.015 CID_359 | CID_359 | |
| 0.018 | 0.134 | 0.044 | Delayed rectifier potassium channel blocker | 0.044 0.016 CID_359 | CID_359 | |
| 0.008 | 0.125 | 0.032 | Estrogen-related receptor gamma agonist | 0.032 0.004 CID_359 | CID_359 | |
| 0.037 | 0.156 | 0.082 | Adenine nucleotide translocase inhibitor | 0.082 0.008 CID_359 | CID_359 | |
| 0.04 | 0.161 | 0.174 | GABA aminotransferase inhibitor | 0.174 0.005 CID_359 0.074 0.054 CID_152432 | CID_359 | |
| 0.026 | 0.15 | 0.073 | Prostaglandin-E synthase inhibitor | 0.073 0.045 CID_359 | CID_359 | |
| 0.03 | 0.155 | 0.055 | Heme oxygenase inhibitor | 0.055 0.009 CID_359 | CID_359 | |
| 0.017 | 0.142 | 0.051 | Thromboxane A2 antagonist | 0.051 0.035 CID_359 | CID_359 | |
| 0.041 | 0.168 | 0.105 | Interferon agonist | 0.105 0.025 CID_359 | CID_359 | |
| 0.026 | 0.153 | 0.065 | Potassium channel (ATP-sensitive) activator | 0.065 0.012 CID_359 | CID_359 | |
| 0.054 | 0.182 | 0.237 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.237 0.032 CID_359 | CID_359 | |
| 0.028 | 0.156 | 0.068 | Potassium channel (Inward rectifier) activator | 0.068 0.013 CID_359 | CID_359 | |
| 0.02 | 0.151 | 0.072 | Acetylcholine M3 receptor antagonist | 0.072 0.03 CID_359 | CID_359 | |
| 0.029 | 0.16 | 0.51 | Porphobilinogen synthase inhibitor | 0.51 0.003 CID_359 0.064 0.062 CID_152432 | CID_359 | |
| 0.014 | 0.145 | 0.035 | Thymidine phosphorylase inhibitor | 0.035 0.008 CID_359 | CID_359 | |
| 0.019 | 0.151 | 0.053 | Thromboxane antagonist | 0.053 0.038 CID_359 | CID_359 | |
| 0.015 | 0.149 | 0.069 | Glutamate (mGluR3) antagonist | 0.069 0.006 CID_359 | CID_359 | |
| 0.014 | 0.152 | 0.105 | Ornithine carbamoyltransferase inhibitor | 0.105 0.015 CID_359 | CID_359 | |
| 0.007 | 0.146 | 0.109 | Glutamate (mGluR1a) agonist | 0.109 0.004 CID_359 | CID_359 | |
| 0.004 | 0.143 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.024 0.004 CID_359 | CID_359 | |
| 0.017 | 0.158 | 0.145 | NMDA receptor subunit 3B antagonist | 0.145 0.007 CID_359 | CID_359 | |
| 0.012 | 0.153 | 0.038 | Calcitonin receptor agonist | 0.038 0.021 CID_359 | CID_359 | |
| 0.018 | 0.161 | 0.108 | Mineralocorticoid receptor antagonist | 0.108 0.007 CID_152432 | CID_152432 | |
| 0.002 | 0.146 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 CID_359 | CID_359 | |
| 0.027 | 0.172 | 0.065 | Heparanase inhibitor | 0.065 0.016 CID_359 | CID_359 | |
| 0.06 | 0.205 | 0.185 | Interleukin 12 antagonist | 0.185 0.007 CID_359 0.121 0.028 CID_152432 | CID_359 | |
| 0.126 | 0.271 | 0.195 | ErbB-1 antagonist | 0.195 0.095 CID_359 | CID_359 | |
| 0.007 | 0.156 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.016 CID_359 | CID_359 | |
| 0.011 | 0.16 | 0.047 | Antimetabolite | 0.047 0.034 CID_359 | CID_359 | |
| 0.021 | 0.174 | 0.088 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 CID_359 | CID_359 | |
| 0.007 | 0.16 | 0.061 | Carbonic anhydrase IX inhibitor | 0.061 0.037 CID_359 | CID_359 | |
| 0.08 | 0.238 | 0.201 | Growth hormone agonist | 0.201 0.058 CID_359 | CID_359 | |
| 0.021 | 0.179 | 0.073 | Cyclin-dependent kinase 6 inhibitor | 0.073 0.027 CID_359 | CID_359 | |
| 0.01 | 0.169 | 0.021 | Retinoic acid gamma receptor agonist | 0.021 0.02 CID_359 | CID_359 | |
| 0.018 | 0.179 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 CID_359 | CID_359 | |
| 0.007 | 0.169 | 0.016 | Integrin beta6 antagonist | 0.016 0.007 CID_359 | CID_359 | |
| 0.004 | 0.166 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_359 | CID_359 | |
| 0.01 | 0.173 | 0.064 | Carbonic anhydrase II inhibitor | 0.064 0.032 CID_359 | CID_359 | |
| 0.003 | 0.167 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 CID_359 | CID_359 | |
| 0.022 | 0.189 | 0.144 | NMDA 2B receptor antagonist | 0.144 0.009 CID_359 | CID_359 | |
| 0.023 | 0.19 | 0.081 | Amidase inhibitor | 0.081 0.037 CID_359 | CID_359 | |
| 0.132 | 0.299 | 0.36 | Insulysin inhibitor | 0.36 0.031 CID_359 0.225 0.123 CID_152432 | CID_359 | |
| 0.032 | 0.2 | 0.198 | Potassium channel (Ca-activated) activator | 0.198 0.015 CID_359 | CID_359 | |
| 0.034 | 0.202 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 CID_359 | CID_359 | |
| 0.043 | 0.211 | 0.06 | Prolactin release inhibitor | 0.06 0.054 CID_359 | CID_359 | |
| 0.023 | 0.193 | 0.055 | Aldosterone antagonist | 0.055 0.024 CID_359 | CID_359 | |
| 0.064 | 0.236 | 0.346 | Aryl hydrocarbon receptor agonist | 0.346 0.049 CID_359 | CID_359 | |
| 0.048 | 0.221 | 0.122 | Acetylcholine muscarinic antagonist | 0.122 0.065 CID_359 | CID_359 | |
| 0.103 | 0.277 | 0.246 | Catenin beta inhibitor | 0.246 0.012 CID_359 | CID_359 | |
| 0.011 | 0.185 | 0.091 | Alpha 1d adrenoreceptor agonist | 0.091 0.004 CID_359 | CID_359 | |
| 0.03 | 0.205 | 0.121 | Protein kinase (CK2) inhibitor | 0.121 0.047 CID_359 | CID_359 | |
| 0.027 | 0.202 | 0.075 | Elastase 1 inhibitor | 0.075 0.041 CID_359 | CID_359 | |
| 0.004 | 0.183 | 0.034 | Alpha 2a adrenoreceptor agonist | 0.034 0.005 CID_359 | CID_359 | |
| 0.133 | 0.313 | 0.249 | 5 Hydroxytryptamine 3E antagonist | 0.249 0.016 CID_359 | CID_359 | |
| 0.035 | 0.216 | 0.209 | Aminopeptidase B inhibitor | 0.209 0.019 CID_359 | CID_359 | |
| 0.013 | 0.194 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 CID_359 | CID_359 | |
| 0.031 | 0.212 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.09 0.02 CID_359 | CID_359 | |
| 0.012 | 0.194 | 0.048 | 5 Hydroxytryptamine 2 agonist | 0.048 0.04 CID_359 | CID_359 | |
| 0.016 | 0.2 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.023 CID_359 | CID_359 | |
| 0.008 | 0.192 | 0.06 | Carbonic anhydrase I inhibitor | 0.06 0.035 CID_359 | CID_359 | |
| 0.006 | 0.192 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.006 CID_359 | CID_359 | |
| 0.029 | 0.216 | 0.06 | Factor III inhibitor | 0.06 0.017 CID_359 | CID_359 | |
| 0.003 | 0.191 | 0.019 | Egl nine homolog 1 inhibitor | 0.019 0.006 CID_359 | CID_359 | |
| 0.048 | 0.237 | 0.113 | Cholinergic antagonist | 0.113 0.081 CID_359 | CID_359 | |
| 0.022 | 0.211 | 0.101 | Dopamine beta hydroxylase inhibitor | 0.101 0.004 CID_359 | CID_359 | |
| 0.033 | 0.223 | 0.122 | Inducible nitric-oxide synthase inhibitor | 0.122 0.024 CID_359 | CID_359 | |
| 0.011 | 0.202 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.027 CID_359 | CID_359 | |
| 0.023 | 0.214 | 0.057 | Thromboxane synthase inhibitor | 0.057 0.033 CID_359 | CID_359 | |
| 0.058 | 0.249 | 0.124 | Toll-Like receptor antagonist | 0.124 0.078 CID_359 | CID_359 | |
| 0.047 | 0.239 | 0.109 | Acetylcholine antagonist | 0.109 0.081 CID_359 | CID_359 | |
| 0.036 | 0.229 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.05 CID_359 | CID_359 | |
| 0.033 | 0.226 | 0.15 | Potassium channel large-conductance Ca-activated activator | 0.15 0.011 CID_359 | CID_359 | |
| 0.003 | 0.201 | 0.016 | Egl nine homolog 3 inhibitor | 0.016 0.005 CID_359 | CID_359 | |
| 0.042 | 0.242 | 0.103 | Vanilloid 4 agonist | 0.103 0.014 CID_359 | CID_359 | |
| 0.008 | 0.208 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 CID_359 | CID_359 | |
| 0.021 | 0.223 | 0.087 | Cyclin D1 inhibitor | 0.087 0.013 CID_359 | CID_359 | |
| 0.006 | 0.209 | 0.04 | Lysine carboxypeptidase inhibitor | 0.04 0.01 CID_359 | CID_359 | |
| 0.005 | 0.21 | 0.041 | HCV NS5B polymerase inhibitor | 0.041 0.014 CID_359 | CID_359 | |
| 0.018 | 0.223 | 0.085 | Beta 1 adrenoreceptor antagonist | 0.085 0.015 CID_359 | CID_359 | |
| 0.031 | 0.237 | 0.149 | Histamine N-methyltransferase inhibitor | 0.149 0.014 CID_359 | CID_359 | |
| 0.033 | 0.24 | 0.083 | Adenosine A3 receptor antagonist | 0.083 0.039 CID_359 | CID_359 | |
| 0.025 | 0.233 | 0.059 | Bombesin 2 receptor antagonist | 0.059 0.024 CID_359 | CID_359 | |
| 0.009 | 0.217 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_359 | CID_359 | |
| 0.025 | 0.235 | 0.087 | Potassium channel (ATP-sensitive) blocker | 0.087 0.023 CID_359 | CID_359 | |
| 0.011 | 0.223 | 0.074 | GABA uptake inhibitor | 0.074 0.006 CID_359 | CID_359 | |
| 0.039 | 0.253 | 0.095 | Alpha 2b adrenoreceptor antagonist | 0.095 0.079 CID_359 | CID_359 | |
| 0.001 | 0.215 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_359 | CID_359 | |
| 0.005 | 0.22 | 0.028 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 CID_359 | CID_359 | |
| 0.052 | 0.269 | 0.276 | Mcl-1 antagonist | 0.276 0.028 CID_359 | CID_359 | |
| 0.011 | 0.229 | 0.042 | Leukocyte elastase inhibitor | 0.042 0.031 CID_359 | CID_359 | |
| 0.156 | 0.373 | 0.56 | Calcium channel L-type activator | 0.56 0.011 CID_359 0.412 0.073 CID_152432 | CID_359 | |
| 0.041 | 0.258 | 0.073 | Calcium channel P-type blocker | 0.073 0.022 CID_359 | CID_359 | |
| 0.024 | 0.241 | 0.108 | Phospholipase D inhibitor | 0.108 0.011 CID_359 | CID_359 | |
| 0.015 | 0.235 | 0.079 | TRPA1 antagonist | 0.079 0.026 CID_359 | CID_359 | |
| 0.038 | 0.259 | 0.239 | 5 Hydroxytryptamine 3A agonist | 0.239 0.007 CID_359 | CID_359 | |
| 0.009 | 0.23 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.067 0.014 CID_359 | CID_359 | |
| 0.002 | 0.226 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 CID_359 | CID_359 | |
| 0.002 | 0.226 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 CID_359 | CID_359 | |
| 0.014 | 0.238 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.013 CID_359 | CID_359 | |
| 0.006 | 0.23 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_359 | CID_359 | |
| 0.023 | 0.248 | 0.162 | NMDA receptor antagonist | 0.162 0.021 CID_359 | CID_359 | |
| 0.009 | 0.235 | 0.134 | NMDA 2 receptor antagonist | 0.134 0.02 CID_359 | CID_359 | |
| 0.005 | 0.231 | 0.013 | Cyclin D2 inhibitor | 0.013 0.009 CID_359 | CID_359 | |
| 0.085 | 0.311 | 0.286 | 5 Hydroxytryptamine 1E antagonist | 0.286 0.04 CID_359 | CID_359 | |
| 0.029 | 0.255 | 0.084 | Interferon inducer | 0.084 0.021 CID_359 | CID_359 | |
| 0.013 | 0.239 | 0.07 | Cyclin B2 inhibitor | 0.07 0.021 CID_359 | CID_359 | |
| 0.019 | 0.245 | 0.07 | Alpha adrenoreceptor agonist | 0.07 0.045 CID_359 | CID_359 | |
| 0.065 | 0.292 | 0.432 | Interleukin antagonist | 0.432 0.026 CID_359 0.158 0.112 CID_152432 | CID_359 | |
| 0.004 | 0.232 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.007 CID_359 | CID_359 | |
| 0.015 | 0.243 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.042 0.022 CID_359 | CID_359 | |
| 0.016 | 0.248 | 0.065 | AICAR transformylase inhibitor | 0.065 0.012 CID_359 | CID_359 | |
| 0.015 | 0.248 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.027 CID_359 | CID_359 | |
| 0.009 | 0.245 | 0.101 | NMDA 2A receptor antagonist | 0.101 0.013 CID_359 | CID_359 | |
| 0.005 | 0.241 | 0.06 | Urate transporter 1 inhibitor | 0.06 0.014 CID_359 | CID_359 | |
| 0.003 | 0.239 | 0.02 | Cyclin T1 inhibitor | 0.02 0.01 CID_359 | CID_359 | |
| 0.033 | 0.27 | 0.101 | Exportin-1 inhibitor | 0.101 0.009 CID_359 0.077 0.03 CID_152432 | CID_359 | |
| 0.096 | 0.335 | 0.287 | Gastrin inhibitor | 0.287 0.042 CID_359 | CID_359 | |
| 0.03 | 0.269 | 0.099 | Potassium channel activator | 0.099 0.049 CID_359 | CID_359 | |
| 0.012 | 0.253 | 0.059 | Nerve growth factor antagonist | 0.059 0.01 CID_359 | CID_359 | |
| 0.004 | 0.247 | 0.04 | Nicotinic alpha4beta2 receptor agonist | 0.04 0.008 CID_359 | CID_359 | |
| 0.007 | 0.25 | 0.036 | Liver X receptor beta agonist | 0.036 0.019 CID_359 | CID_359 | |
| 0.053 | 0.298 | 0.189 | Interleukin 8 antagonist | 0.189 0.016 CID_359 | CID_359 | |
| 0.015 | 0.263 | 0.073 | Cyclin B1 inhibitor | 0.073 0.028 CID_359 | CID_359 | |
| 0.027 | 0.277 | 0.069 | DNA helicase inhibitor | 0.069 0.018 CID_359 | CID_359 | |
| 0.017 | 0.269 | 0.045 | Neurotensin receptor antagonist | 0.045 0.032 CID_359 | CID_359 | |
| 0.001 | 0.253 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 CID_359 | CID_359 | |
| 0.011 | 0.263 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 CID_359 | CID_359 | |
| 0.021 | 0.275 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 CID_359 | CID_359 | |
| 0.023 | 0.277 | 0.116 | Cathepsin G inhibitor | 0.116 0.028 CID_359 0.073 0.05 CID_152432 | CID_359 | |
| 0.009 | 0.265 | 0.115 | NMDA 2C receptor antagonist | 0.115 0.012 CID_359 | CID_359 | |
| 0.02 | 0.276 | 0.062 | Glutamate (mGluR group III) antagonist | 0.062 0.012 CID_359 | CID_359 | |
| 0.006 | 0.262 | 0.043 | Nicotinic acid receptor 2 antagonist | 0.043 0.004 CID_359 | CID_359 | |
| 0.008 | 0.265 | 0.033 | Liver X receptor alpha antagonist | 0.033 0.015 CID_359 | CID_359 | |
| 0.008 | 0.266 | 0.031 | Liver X receptor antagonist | 0.031 0.021 CID_359 | CID_359 | |
| 0.071 | 0.33 | 0.168 | Pregnane X receptor agonist | 0.168 0.028 CID_359 | CID_359 | |
| 0.019 | 0.28 | 0.177 | Anesthetic local | 0.167 0.042 CID_359 0.177 0.039 CID_152432 | CID_152432 | |
| 0.007 | 0.271 | 0.098 | Dihydropteroate synthase inhibitor | 0.098 0.005 CID_359 | CID_359 | |
| 0.062 | 0.327 | 0.171 | Sigma receptor agonist | 0.171 0.073 CID_359 | CID_359 | |
| 0.032 | 0.297 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.074 0.009 CID_359 | CID_359 | |
| 0.027 | 0.294 | 0.19 | Falcipain 3 inhibitor | 0.19 0.021 CID_359 | CID_359 | |
| 0.039 | 0.308 | 0.193 | Cytidine deaminase inhibitor | 0.193 0.051 CID_359 | CID_359 | |
| 0.018 | 0.287 | 0.063 | Lysine-specific demethylase 1A inhibitor | 0.063 0.025 CID_359 | CID_359 | |
| 0.042 | 0.312 | 0.175 | Cathepsin H inhibitor | 0.175 0.031 CID_359 | CID_359 | |
| 0.02 | 0.29 | 0.135 | Protein kinase (CK2) alpha inhibitor | 0.135 0.052 CID_359 | CID_359 | |
| 0.042 | 0.314 | 0.122 | Interleukin 5 antagonist | 0.122 0.022 CID_359 | CID_359 | |
| 0.012 | 0.284 | 0.104 | NMDA receptor glycine site agonist | 0.104 0.014 CID_359 | CID_359 | |
| 0.047 | 0.32 | 0.143 | Acetylcholine release stimulant | 0.143 0.022 CID_359 | CID_359 | |
| 0.006 | 0.28 | 0.045 | Liver X receptor beta antagonist | 0.045 0.01 CID_359 | CID_359 | |
| 0.054 | 0.328 | 0.153 | Cyclin-dependent kinase 8 inhibitor | 0.153 0.076 CID_359 | CID_359 | |
| 0.057 | 0.334 | 0.402 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.402 0.038 CID_359 | CID_359 | |
| 0.009 | 0.286 | 0.058 | Adenosine A1 receptor antagonist | 0.058 0.041 CID_359 | CID_359 | |
| 0.008 | 0.285 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 CID_359 | CID_359 | |
| 0.009 | 0.287 | 0.046 | Glutamate (mGluR1) agonist | 0.046 0.005 CID_359 | CID_359 | |
| 0.017 | 0.295 | 0.08 | Acetylcholine nicotinic antagonist | 0.08 0.055 CID_359 | CID_359 | |
| 0.011 | 0.291 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 CID_359 | CID_359 | |
| 0.012 | 0.293 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.028 CID_359 | CID_359 | |
| 0.063 | 0.345 | 0.279 | Prostaglandin dehydrogenase inhibitor | 0.279 0.112 CID_359 | CID_359 | |
| 0.044 | 0.327 | 0.117 | Cytokine production inhibitor | 0.117 0.093 CID_359 | CID_359 | |
| 0.013 | 0.298 | 0.07 | Neuronal nicotinic receptor antagonist | 0.07 0.045 CID_359 | CID_359 | |
| 0.013 | 0.298 | 0.047 | Potassium channel (Inward rectifier) blocker | 0.047 0.038 CID_359 | CID_359 | |
| 0.011 | 0.296 | 0.063 | Cyclin B inhibitor | 0.063 0.028 CID_359 | CID_359 | |
| 0.035 | 0.321 | 0.136 | MAP kinase kinase 1 inhibitor | 0.136 0.023 CID_359 | CID_359 | |
| 0.007 | 0.295 | 0.046 | Phosphodiesterase 3B inhibitor | 0.046 0.029 CID_359 | CID_359 | |
| 0.019 | 0.306 | 0.064 | 5 Hydroxytryptamine 7 agonist | 0.064 0.026 CID_359 | CID_359 | |
| 0.02 | 0.308 | 0.112 | NMDA receptor agonist | 0.112 0.015 CID_359 | CID_359 | |
| 0.045 | 0.335 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 CID_359 | CID_359 | |
| 0.059 | 0.349 | 0.197 | Sphingosine 1-phosphate receptor 2 antagonist | 0.197 0.008 CID_359 | CID_359 | |
| 0.008 | 0.299 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.016 CID_359 | CID_359 | |
| 0.003 | 0.295 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 CID_359 | CID_359 | |
| 0.016 | 0.31 | 0.057 | Cytokine production stimulant | 0.057 0.016 CID_359 | CID_359 | |
| 0.026 | 0.32 | 0.108 | Somatostatin 1 agonist | 0.108 0.029 CID_359 | CID_359 | |
| 0.005 | 0.3 | 0.044 | Free fatty acid receptor 1 antagonist | 0.044 0.013 CID_359 | CID_359 | |
| 0.031 | 0.327 | 0.125 | Toll-Like receptor 9 antagonist | 0.125 0.081 CID_359 | CID_359 | |
| 0.004 | 0.301 | 0.026 | Kynurenine 3 monooxygenase inhibitor | 0.026 0.019 CID_359 | CID_359 | |
| 0.029 | 0.326 | 0.363 | Ferrochelatase inhibitor | 0.363 0.004 CID_359 | CID_359 | |
| 0.011 | 0.309 | 0.077 | Acetylcholine M5 receptor agonist | 0.077 0.036 CID_359 | CID_359 | |
| 0.046 | 0.346 | 0.134 | MAP3K9 inhibitor | 0.134 0.087 CID_359 | CID_359 | |
| 0.013 | 0.32 | 0.2 | Catalase inhibitor | 0.2 0.015 CID_359 0.126 0.032 CID_152432 | CID_359 | |
| 0.045 | 0.354 | 0.274 | MAP kinase kinase 2 inhibitor | 0.274 0.044 CID_359 | CID_359 | |
| 0.019 | 0.329 | 0.06 | Sirtuin 1 inhibitor | 0.06 0.059 CID_359 | CID_359 | |
| 0.011 | 0.322 | 0.05 | Membrane dipeptidase inhibitor | 0.05 0.016 CID_359 | CID_359 | |
| 0.004 | 0.322 | 0.042 | Sirtuin 2 inhibitor | 0.034 0.022 CID_359 0.042 0.016 CID_152432 | CID_152432 | |
| 0.005 | 0.328 | 0.071 | Geranyltranstransferase inhibitor | 0.071 0.007 CID_359 | CID_359 | |
| 0.06 | 0.385 | 0.141 | MAP kinase 3 inhibitor | 0.141 0.083 CID_359 | CID_359 | |
| 0.032 | 0.356 | 0.098 | Phosphodiesterase I inhibitor | 0.098 0.047 CID_359 | CID_359 | |
| 0.011 | 0.336 | 0.052 | Dihydroorotase inhibitor | 0.052 0.022 CID_359 | CID_359 | |
| 0.07 | 0.397 | 0.206 | Sphingosine 1-phosphate receptor 5 antagonist | 0.206 0.009 CID_359 | CID_359 | |
| 0.02 | 0.347 | 0.066 | Nicotinic alpha3beta2 receptor antagonist | 0.066 0.02 CID_359 | CID_359 | |
| 0.001 | 0.329 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.01 CID_359 | CID_359 | |
| 0.003 | 0.331 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 CID_359 | CID_359 | |
| 0.023 | 0.353 | 0.09 | Cyclin-dependent kinase 9 inhibitor | 0.09 0.075 CID_359 | CID_359 | |
| 0.014 | 0.348 | 0.135 | Purinergic P2X2 antagonist | 0.135 0.015 CID_359 | CID_359 | |
| 0.008 | 0.343 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.052 CID_359 | CID_359 | |
| 0.013 | 0.348 | 0.121 | Sphingosine 1-phosphate receptor 4 agonist | 0.121 0.016 CID_359 | CID_359 | |
| 0.01 | 0.349 | 0.038 | Integrin alpha2 antagonist | 0.038 0.023 CID_359 | CID_359 | |
| 0.01 | 0.35 | 0.032 | Complement factor 1s inhibitor | 0.032 0.006 CID_359 | CID_359 | |
| 0.024 | 0.367 | 0.118 | Nitric-oxide synthase inhibitor | 0.118 0.039 CID_359 | CID_359 | |
| 0.006 | 0.349 | 0.018 | Caspase 8 inhibitor | 0.018 0.016 CID_359 | CID_359 | |
| 0.015 | 0.359 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 CID_359 | CID_359 | |
| 0.045 | 0.39 | 0.138 | Histone deacetylase SIRT1 inhibitor | 0.138 0.072 CID_359 0.118 0.094 CID_152432 | CID_359 | |
| 0.011 | 0.36 | 0.1 | Nicotinic alpha4beta2 receptor antagonist | 0.1 0.031 CID_359 | CID_359 | |
| 0.005 | 0.355 | 0.04 | Kinesin antagonist | 0.04 0.022 CID_359 | CID_359 | |
| 0.005 | 0.355 | 0.04 | Kinesin-like protein 1 inhibitor | 0.04 0.022 CID_359 | CID_359 | |
| 0.006 | 0.357 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.035 0.022 CID_359 | CID_359 | |
| 0.008 | 0.362 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.025 CID_359 | CID_359 | |
| 0.004 | 0.358 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 CID_359 | CID_359 | |
| 0.078 | 0.431 | 0.251 | Transcription factor inhibitor | 0.251 0.186 CID_359 | CID_359 | |
| 0.018 | 0.372 | 0.1 | 5 Hydroxytryptamine 3 agonist | 0.1 0.015 CID_359 | CID_359 | |
| 0.007 | 0.362 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.015 CID_359 | CID_359 | |
| 0.01 | 0.366 | 0.052 | Dopamine transporter inhibitor | 0.052 0.03 CID_152432 | CID_152432 | |
| 0.007 | 0.365 | 0.034 | Protein kinase C beta II inhibitor | 0.034 0.019 CID_359 | CID_359 | |
| 0.007 | 0.366 | 0.024 | ICAM 1 antagonist | 0.024 0.014 CID_359 | CID_359 | |
| 0.059 | 0.42 | 0.264 | DNA polymerase beta inhibitor | 0.264 0.184 CID_359 | CID_359 | |
| 0.009 | 0.377 | 0.059 | Acetylcholine M5 receptor antagonist | 0.059 0.043 CID_359 | CID_359 | |
| 0.004 | 0.375 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.007 CID_359 | CID_359 | |
| 0.016 | 0.389 | 0.073 | Calcium antagonist | 0.073 0.07 CID_359 | CID_359 | |
| 0.03 | 0.403 | 0.184 | Electrolyte absorption antagonist | 0.184 0.01 CID_359 | CID_359 | |
| 0.01 | 0.383 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 CID_359 | CID_359 | |
| 0.013 | 0.387 | 0.034 | Adenosine uptake inhibitor | 0.034 0.025 CID_359 | CID_359 | |
| 0.013 | 0.388 | 0.082 | Sphingosine 1-phosphate receptor 3 antagonist | 0.082 0.016 CID_359 | CID_359 | |
| 0.002 | 0.377 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 CID_359 | CID_359 | |
| 0.033 | 0.409 | 0.141 | Interleukin 1b antagonist | 0.141 0.046 CID_359 | CID_359 | |
| 0.031 | 0.409 | 0.23 | I kappa B kinase epsilon inhibitor | 0.23 0.049 CID_359 | CID_359 | |
| 0.037 | 0.418 | 0.179 | Interleukin 1 antagonist | 0.179 0.042 CID_359 | CID_359 | |
| 0.011 | 0.393 | 0.078 | Acetylcholine nicotinic agonist | 0.078 0.059 CID_359 | CID_359 | |
| 0.008 | 0.391 | 0.059 | Dihydroorotate dehydrogenase inhibitor | 0.059 0.029 CID_359 | CID_359 | |
| 0.006 | 0.39 | 0.048 | CDK5/p25 inhibitor | 0.048 0.023 CID_359 | CID_359 | |
| 0.141 | 0.526 | 0.482 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.482 0.042 CID_359 | CID_359 | |
| 0.05 | 0.441 | 0.231 | 3C-like protease (Human coronavirus) inhibitor | 0.231 0.036 CID_359 | CID_359 | |
| 0.025 | 0.417 | 0.138 | Caspase 3 inhibitor | 0.138 0.038 CID_359 | CID_359 | |
| 0.006 | 0.403 | 0.06 | Thymidylate synthase inhibitor | 0.06 0.017 CID_359 | CID_359 | |
| 0.032 | 0.429 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 CID_359 | CID_359 | |
| 0.044 | 0.442 | 0.42 | Streptokinase A inhibitor | 0.42 0.042 CID_359 | CID_359 | |
| 0.012 | 0.414 | 0.077 | Adrenaline uptake inhibitor | 0.077 0.029 CID_152432 | CID_152432 | |
| 0.018 | 0.42 | 0.103 | CXC chemokine 1 receptor antagonist | 0.103 0.005 CID_359 | CID_359 | |
| 0.017 | 0.428 | 0.161 | MAP kinase kinase inhibitor | 0.161 0.046 CID_359 | CID_359 | |
| 0.017 | 0.429 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.044 CID_359 | CID_359 | |
| 0.004 | 0.417 | 0.053 | Adenosine A2a receptor antagonist | 0.053 0.052 CID_359 | CID_359 | |
| 0.012 | 0.426 | 0.067 | Glutamate (mGluR group III) agonist | 0.067 0.016 CID_359 | CID_359 | |
| 0.006 | 0.423 | 0.08 | Nicotinic acid receptor agonist | 0.08 0.006 CID_359 | CID_359 | |
| 0.009 | 0.432 | 0.041 | Glutamate (mGluR4) agonist | 0.041 0.015 CID_359 | CID_359 | |
| 0.007 | 0.432 | 0.047 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.045 CID_359 | CID_359 | |
| 0.007 | 0.438 | 0.052 | Glycine transporter 2 inhibitor | 0.052 0.029 CID_359 | CID_359 | |
| 0.014 | 0.45 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.037 CID_359 | CID_359 | |
| 0.034 | 0.472 | 0.163 | Sphingosine 1-phosphate receptor 4 antagonist | 0.163 0.023 CID_359 | CID_359 | |
| 0.016 | 0.454 | 0.076 | GABA A receptor agonist | 0.076 0.072 CID_359 | CID_359 | |
| 0.013 | 0.455 | 0.121 | Glycogen synthase kinase-3 alpha inhibitor | 0.121 0.084 CID_359 | CID_359 | |
| 0.017 | 0.465 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 CID_359 | CID_359 | |
| 0.003 | 0.455 | 0.052 | Kainate receptor antagonist | 0.052 0.02 CID_359 | CID_359 | |
| 0.012 | 0.466 | 0.044 | Potassium channel Kv1.1 blocker | 0.044 0.018 CID_359 | CID_359 | |
| 0.021 | 0.477 | 0.172 | Nav1.6 sodium channel blocker | 0.172 0.034 CID_359 | CID_359 | |
| 0.013 | 0.472 | 0.061 | I kappa B kinase 2 inhibitor | 0.061 0.045 CID_359 | CID_359 | |
| 0.02 | 0.48 | 0.114 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.114 0.028 CID_359 | CID_359 | |
| 0.007 | 0.474 | 0.06 | AMPA 4 receptor antagonist | 0.06 0.01 CID_359 | CID_359 | |
| 0.007 | 0.478 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.029 CID_359 | CID_359 | |
| 0.035 | 0.506 | 0.156 | Thiol protease inhibitor | 0.156 0.064 CID_359 | CID_359 | |
| 0.018 | 0.491 | 0.111 | GABA receptor agonist | 0.111 0.066 CID_359 | CID_359 | |
| 0.004 | 0.479 | 0.039 | Purinergic P2Y antagonist | 0.039 0.038 CID_359 | CID_359 | |
| 0.006 | 0.482 | 0.046 | Histamine H1 receptor agonist | 0.046 0.024 CID_359 | CID_359 | |
| 0.003 | 0.48 | 0.042 | Diamine oxidase inhibitor | 0.042 0.021 CID_359 | CID_359 | |
| 0.014 | 0.494 | 0.074 | I kappa B kinase inhibitor | 0.074 0.07 CID_359 | CID_359 | |
| 0.038 | 0.519 | 0.208 | Thyroid hormone antagonist | 0.208 0.155 CID_359 | CID_359 | |
| 0.039 | 0.521 | 0.19 | Thyroid hormone beta antagonist | 0.19 0.163 CID_359 | CID_359 | |
| 0.013 | 0.497 | 0.065 | Glutamate (mGluR4) antagonist | 0.065 0.012 CID_359 | CID_359 | |
| 0.015 | 0.5 | 0.094 | Caspase 7 inhibitor | 0.094 0.035 CID_359 | CID_359 | |
| 0.006 | 0.492 | 0.03 | CDK4/cyclin D3 inhibitor | 0.03 0.018 CID_359 | CID_359 | |
| 0.019 | 0.507 | 0.075 | Phosphodiesterase 1C inhibitor | 0.075 0.024 CID_359 | CID_359 | |
| 0.015 | 0.504 | 0.071 | Histone deacetylase SIRT3 inhibitor | 0.071 0.026 CID_359 | CID_359 | |
| 0.01 | 0.505 | 0.072 | Epithelial sodium channel blocker | 0.072 0.017 CID_359 | CID_359 | |
| 0.027 | 0.528 | 0.125 | Nav1.2 sodium channel blocker | 0.125 0.078 CID_359 | CID_359 | |
| 0.004 | 0.509 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 CID_359 | CID_359 | |
| 0.004 | 0.513 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | 0.034 0.01 CID_359 | CID_359 | |
| 0.017 | 0.526 | 0.062 | Phosphodiesterase 1B inhibitor | 0.062 0.04 CID_359 | CID_359 | |
| 0.005 | 0.522 | 0.032 | Histone deacetylase 7 inhibitor | 0.032 0.031 CID_359 | CID_359 | |
| 0.016 | 0.538 | 0.128 | Interleukin 1 beta converting enzyme inhibitor | 0.128 0.029 CID_359 0.119 0.036 CID_152432 | CID_359 | |
| 0.003 | 0.526 | 0.037 | AMPA 3 receptor antagonist | 0.037 0.016 CID_359 | CID_359 | |
| 0.075 | 0.607 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.038 CID_359 | CID_359 | |
| 0.004 | 0.538 | 0.027 | Peptide deformylase inhibitor | 0.027 0.024 CID_359 | CID_359 | |
| 0.01 | 0.548 | 0.074 | Bcr-Abl kinase inhibitor | 0.074 0.072 CID_359 | CID_359 | |
| 0.002 | 0.54 | 0.037 | AMPA 1 receptor antagonist | 0.037 0.016 CID_359 | CID_359 | |
| 0.002 | 0.546 | 0.041 | CXC chemokine 2 receptor antagonist | 0.041 0.008 CID_359 | CID_359 | |
| 0.007 | 0.559 | 0.039 | MAP3K5 inhibitor | 0.039 0.027 CID_359 | CID_359 | |
| 0.006 | 0.559 | 0.046 | Histamine H2 receptor agonist | 0.046 0.026 CID_359 | CID_359 | |
| 0.025 | 0.578 | 0.101 | Nav1.1 sodium channel blocker | 0.101 0.065 CID_359 | CID_359 | |
| 0.011 | 0.569 | 0.098 | Thiazolidinedione | 0.098 0.002 CID_152432 | CID_152432 | |
| 0.034 | 0.593 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.149 0.075 CID_359 | CID_359 | |
| 0.02 | 0.584 | 0.103 | Bromodomain-containing protein 2 inhibitor | 0.103 0.037 CID_359 | CID_359 | |
| 0.012 | 0.577 | 0.156 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.156 0.069 CID_359 | CID_359 | |
| 0.002 | 0.573 | 0.038 | Kainate receptor 2 antagonist | 0.038 0.023 CID_359 | CID_359 | |
| 0.002 | 0.58 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_359 | CID_359 | |
| 0.003 | 0.586 | 0.054 | AMPA receptor antagonist | 0.054 0.028 CID_359 | CID_359 | |
| 0.002 | 0.588 | 0.023 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.021 CID_359 | CID_359 | |
| 0.014 | 0.603 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.072 0.026 CID_359 | CID_359 | |
| 0.008 | 0.599 | 0.036 | Erythropoietin receptor agonist | 0.036 0.033 CID_359 | CID_359 | |
| 0.008 | 0.599 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.029 CID_359 | CID_359 | |
| 0.009 | 0.602 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 CID_359 | CID_359 | |
| 0.018 | 0.613 | 0.198 | Thioredoxin glutathione reductase inhibitor | 0.198 0.174 CID_359 | CID_359 | |
| 0.003 | 0.598 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.032 CID_359 | CID_359 | |
| 0.017 | 0.618 | 0.238 | Calpain inhibitor | 0.238 0.076 CID_359 | CID_359 | |
| 0.011 | 0.624 | 0.044 | CC chemokine 4 receptor antagonist | 0.044 0.037 CID_359 | CID_359 | |
| 0.031 | 0.644 | 0.248 | Neuropeptide Y2 antagonist | 0.248 0.058 CID_359 | CID_359 | |
| 0.056 | 0.675 | 0.197 | Cyclin-dependent kinase 3 inhibitor | 0.197 0.035 CID_359 | CID_359 | |
| 0.008 | 0.632 | 0.149 | LIM domain kinase 1 inhibitor | 0.149 0.098 CID_359 | CID_359 | |
| 0.013 | 0.645 | 0.117 | Histone deacetylase class III inhibitor | 0.117 0.072 CID_152432 | CID_152432 | |
| 0.018 | 0.655 | 0.11 | Nav1.3 sodium channel blocker | 0.11 0.086 CID_359 | CID_359 | |
| 0.017 | 0.658 | 0.158 | Neuropeptide Y1 antagonist | 0.158 0.053 CID_359 | CID_359 | |
| 0.008 | 0.663 | 0.122 | M17 leucyl aminopeptidase inhibitor | 0.122 0.075 CID_359 | CID_359 | |
| 0.036 | 0.697 | 0.213 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.213 0.143 CID_359 | CID_359 | |
| 0.016 | 0.683 | 0.158 | Focal adhesion kinase 2 inhibitor | 0.158 0.118 CID_359 | CID_359 | |
| 0.011 | 0.68 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.071 CID_359 | CID_359 | |
| 0.018 | 0.696 | 0.12 | Nav1.4 sodium channel blocker | 0.12 0.052 CID_359 | CID_359 | |
| 0.004 | 0.705 | 0.042 | Nicotinic acid receptor 2 agonist | 0.042 0.019 CID_359 | CID_359 | |
| 0.007 | 0.727 | 0.084 | Polo-like kinase-1 inhibitor | 0.084 0.074 CID_359 | CID_359 | |
| 0.004 | 0.729 | 0.074 | Fibroblast growth factor 4 antagonist | 0.074 0.023 CID_359 | CID_359 | |
| 0.005 | 0.758 | 0.312 | Calpain 2 inhibitor | 0.312 0.107 CID_359 | CID_359 | |
| 0.004 | 0.758 | 0.1 | Fibroblast growth factor 1 antagonist | 0.1 0.058 CID_359 | CID_359 | |
| 0.04 | 0.815 | 0.127 | Death-associated protein kinase 1 inhibitor | 0.127 0.089 CID_359 | CID_359 | |
| 0.01 | 0.859 | 0.068 | Phosphodiesterase VIII inhibitor | 0.068 0.058 CID_152432 | CID_152432 | |
| 0.004 | 0.901 | 0.11 | Glutamate receptor antagonist | 0.11 0.085 CID_359 | CID_359 | |
| 0.004 | 0.91 | 0.068 | Histone deacetylase SIRT2 inhibitor | 0.068 0.058 CID_152432 | CID_152432 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |